3,3',5,5'-tetrachlorobiphenyl-4,4'-diol : A member of the class of hydroxybiphenyls formed formally by chlorination of biphenyl-4,4'-diol at C-3, -3', -5 and -5'.
ID Source | ID |
---|---|
PubMed CID | 97032 |
CHEMBL ID | 83116 |
CHEBI ID | 35434 |
SCHEMBL ID | 463718 |
Synonym |
---|
BIDD:ER0035 |
CHEBI:35434 , |
3,3',5,5'-tetrachloro-[1,1'-biphenyl]-4,4'-diol |
CHEMBL83116 , |
3,5,3',5'-tetrachloro-biphenyl-4,4'-diol |
nsc-97348 |
nsc97348 |
13049-13-3 |
4,4'-biphenyldiol, 3,3',5,5'-tetrachloro- (8ci) |
4,4'-biphenyldiol, 3,3',5,5'-tetrachloro- |
3,3',5,5'-tetrachloro-4,4'-biphenyldiol |
4,4'-dihydroxy-3,3',5,5'-tetrachlorobiphenyl |
[1,1'-biphenyl]-4,4'-diol, 3,3',5,5'-tetrachloro- |
p,p'-biphenol, 2,2',6,6'-tetrachloro- (6ci,7ci) |
[1,1'-biphenyl]-4,4'-diol, 3,3',5,5'-tetrachloro- (9ci) |
3,3',5,5'-tetrachlorobiphenyl-4,4'-diol |
1G3M |
DB03346 |
2G5U |
nsc 97348 |
OPREA1_420775 |
2,6-dichloro-4-(3,5-dichloro-4-hydroxyphenyl)phenol |
AKOS024341184 |
unii-ohs8k6j04i |
ohs8k6j04i , |
bdbm50410534 |
(1,1'-biphenyl)-4,4'-diol, 3,3',5,5'-tetrachloro- |
3,3',5,5'-tetrachloro(1,1'-biphenyl)-4,4'-diol |
SCHEMBL463718 |
cambridge id 5105620 |
YCYDXOVJXVALHY-UHFFFAOYSA-N |
3,3',5,5'-tetrachloro[1,1'-biphenyl]-4,4'-diol # |
DTXSID5022352 |
3,3',5,5'-tetrachloro-4,4'-dihydroxybiphenyl(tcdhb) |
Q27094287 |
4,4/'-biphenyldiol, 3,3/',5,5/'-tetrachloro- |
PD007065 |
Class | Description |
---|---|
dichlorobenzene | Any member of the class of chlorobenzenes carrying two chloro groups at unspecified positions. |
hydroxybiphenyls | Any member of the class of biphenyls that has one or more hydroxy groups attached to the benzenoid ring system. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Protein | Taxonomy | Measurement | Average | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
Chain B, ESTROGEN SULFOTRANSFERASE | Homo sapiens (human) | IC50 (µMol) | 0.0001 | 0.0001 | 0.0001 | 0.0001 | AID977608 |
Transthyretin | Homo sapiens (human) | IC50 (µMol) | 1.5874 | 0.1600 | 4.2921 | 10.0000 | AID1322954 |
Androgen receptor | Rattus norvegicus (Norway rat) | IC50 (µMol) | 38.0189 | 0.0010 | 1.9794 | 14.1600 | AID255211 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Protein | Taxonomy | Measurement | Average | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
Chain A, Transthyretin | Homo sapiens (human) | Kd | 0.0032 | 0.0032 | 0.0032 | 0.0032 | AID977611 |
Chain B, Transthyretin | Homo sapiens (human) | Kd | 0.0032 | 0.0032 | 0.0032 | 0.0032 | AID977611 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Process | via Protein(s) | Taxonomy |
---|---|---|
signal transduction | Transthyretin | Homo sapiens (human) |
purine nucleobase metabolic process | Transthyretin | Homo sapiens (human) |
[Information is prepared from geneontology information from the June-17-2024 release] |
Process | via Protein(s) | Taxonomy |
---|---|---|
hormone activity | Transthyretin | Homo sapiens (human) |
protein binding | Transthyretin | Homo sapiens (human) |
identical protein binding | Transthyretin | Homo sapiens (human) |
thyroid hormone binding | Transthyretin | Homo sapiens (human) |
[Information is prepared from geneontology information from the June-17-2024 release] |
Process | via Protein(s) | Taxonomy |
---|---|---|
extracellular region | Transthyretin | Homo sapiens (human) |
extracellular space | Transthyretin | Homo sapiens (human) |
azurophil granule lumen | Transthyretin | Homo sapiens (human) |
extracellular exosome | Transthyretin | Homo sapiens (human) |
extracellular space | Transthyretin | Homo sapiens (human) |
[Information is prepared from geneontology information from the June-17-2024 release] |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID161431 | Thyroxine binding constant on human plasma prealbumin. | 1986 | Journal of medicinal chemistry, Dec, Volume: 29, Issue:12 | A theoretical study of the binding of polychlorinated biphenyls (PCBs), dibenzodioxins, and dibenzofuran to human plasma prealbumin. |
AID1054848 | Inhibition of human recombinant TTR Y78F mutant-mediated fibrillogenesis after 30 mins by turbidimetric assay | 2013 | Journal of medicinal chemistry, Nov-27, Volume: 56, Issue:22 | Modulation of the fibrillogenesis inhibition properties of two transthyretin ligands by halogenation. |
AID230635 | KPCB/ K352 ratio of the compound | 1986 | Journal of medicinal chemistry, Dec, Volume: 29, Issue:12 | A theoretical study of the binding of polychlorinated biphenyls (PCBs), dibenzodioxins, and dibenzofuran to human plasma prealbumin. |
AID210552 | Relative binding affinity for nuclear receptor from rat liver compared to thyroxine (T4) as KA(comp)/KA(T4 | 1987 | Journal of medicinal chemistry, Jan, Volume: 30, Issue:1 | Polychlorinated biphenyls and related compound interactions with specific binding sites for thyroxine in rat liver nuclear extracts. |
AID161430 | Displacement of [125I]thyroxin from human plasma prealbumin. | 1986 | Journal of medicinal chemistry, Dec, Volume: 29, Issue:12 | A theoretical study of the binding of polychlorinated biphenyls (PCBs), dibenzodioxins, and dibenzofuran to human plasma prealbumin. |
AID161435 | Relative binding affinity for thyroxin binding prealbumin (TBPA) from rat liver compared to thyroxine (T4) as KA(comp)/KA(T4) | 1987 | Journal of medicinal chemistry, Jan, Volume: 30, Issue:1 | Polychlorinated biphenyls and related compound interactions with specific binding sites for thyroxine in rat liver nuclear extracts. |
AID1322954 | Stabilization of recombinant human wild type TTR expressed in Escherichia coli BL21 (DE3) assessed as inhibition of amyloid beta formation by measuring turbidity preincubated for 30 mins followed by lowering pH from 7.2 to 4.4 measured after 72 hrs by mic | 2016 | European journal of medicinal chemistry, Oct-04, Volume: 121 | A novel bis-furan scaffold for transthyretin stabilization and amyloid inhibition. |
AID1486518 | Inhibition of acid-induced wild type transthyretin (unknown origin) aggregation expressed in Escherichia coli pre-incubated for 30 mins before acid addition and further incubated for 72 hrs at 37 degC under dark conditions by UV-Vis spectrophotometry | 2017 | Bioorganic & medicinal chemistry letters, 08-01, Volume: 27, Issue:15 | Semi-quantitative models for identifying potent and selective transthyretin amyloidogenesis inhibitors. |
AID1054847 | Inhibition of human recombinant TTR Y78F mutant-mediated fibrillogenesis at 40 uM after 30 mins by turbidimetric assay relative to control | 2013 | Journal of medicinal chemistry, Nov-27, Volume: 56, Issue:22 | Modulation of the fibrillogenesis inhibition properties of two transthyretin ligands by halogenation. |
AID255211 | Inhibitory concentration against recombinant rat androgen receptor expressed in Escherichia coli using [3H]methyltrienolone (R 1881) | 2005 | Journal of medicinal chemistry, Sep-08, Volume: 48, Issue:18 | Impact of induced fit on ligand binding to the androgen receptor: a multidimensional QSAR study to predict endocrine-disrupting effects of environmental chemicals. |
AID161429 | Concentration at which 50% total binding to prealbumin protein. | 1986 | Journal of medicinal chemistry, May, Volume: 29, Issue:5 | Structurally specific binding of halogenated biphenyls to thyroxine transport protein. |
AID1322964 | Cytotoxicity against human HepG2 cells assessed as decrease in cell viability after 72 hrs by resazurin reduction assay | 2016 | European journal of medicinal chemistry, Oct-04, Volume: 121 | A novel bis-furan scaffold for transthyretin stabilization and amyloid inhibition. |
AID1486519 | Binding affinity to transthyretin in human blood plasma assessed as plasma binding selectivity by measuring stoichiometry of small molecule bound to TTR incubated for 24 hrs at 37 degC by RP-HPLC | 2017 | Bioorganic & medicinal chemistry letters, 08-01, Volume: 27, Issue:15 | Semi-quantitative models for identifying potent and selective transthyretin amyloidogenesis inhibitors. |
AID161427 | Relative binding affinity to prealbumin was determined from the competition binding assays and is expressed relative to L-T4 | 1986 | Journal of medicinal chemistry, May, Volume: 29, Issue:5 | Structurally specific binding of halogenated biphenyls to thyroxine transport protein. |
AID1794808 | Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL). | 2014 | Journal of biomolecular screening, Jul, Volume: 19, Issue:6 | A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum. |
AID1794808 | Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL). | |||
AID1811 | Experimentally measured binding affinity data derived from PDB | 2004 | Chemistry & biology, Dec, Volume: 11, Issue:12 | Hydroxylated polychlorinated biphenyls selectively bind transthyretin in blood and inhibit amyloidogenesis: rationalizing rodent PCB toxicity. |
AID977611 | Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB | 2004 | Chemistry & biology, Dec, Volume: 11, Issue:12 | Hydroxylated polychlorinated biphenyls selectively bind transthyretin in blood and inhibit amyloidogenesis: rationalizing rodent PCB toxicity. |
AID977608 | Experimentally measured binding affinity data (IC50) for protein-ligand complexes derived from PDB | 2003 | Environmental health perspectives, Jun, Volume: 111, Issue:7 | Crystallographic analysis of a hydroxylated polychlorinated biphenyl (OH-PCB) bound to the catalytic estrogen binding site of human estrogen sulfotransferase. |
AID1811 | Experimentally measured binding affinity data derived from PDB | 2003 | Environmental health perspectives, Jun, Volume: 111, Issue:7 | Crystallographic analysis of a hydroxylated polychlorinated biphenyl (OH-PCB) bound to the catalytic estrogen binding site of human estrogen sulfotransferase. |
AID1159537 | qHTS screening for TAG (triacylglycerol) accumulators in algae | 2017 | Plant physiology, Aug, Volume: 174, Issue:4 | Identification and Metabolite Profiling of Chemical Activators of Lipid Accumulation in Green Algae. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 3 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (25.00) | 29.6817 |
2010's | 5 (41.67) | 24.3611 |
2020's | 1 (8.33) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 12 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Substance | Description | Relationhip Strength | Studies | Trials | Classes | Roles |
---|---|---|---|---|---|---|
thyroxine | [no description available] | medium | 1 | 0 | 2-halophenol; amino acid zwitterion; iodophenol; iodothyronine; non-proteinogenic alpha-amino acid; tyrosine derivative | mitogen |
thyroxine | [no description available] | medium | 4 | 0 | 2-halophenol; iodophenol; L-phenylalanine derivative; non-proteinogenic L-alpha-amino acid; thyroxine zwitterion; thyroxine | antithyroid drug; human metabolite; mouse metabolite; thyroid hormone |
triiodothyronine | [no description available] | medium | 2 | 0 | 2-halophenol; amino acid zwitterion; iodophenol; iodothyronine | human metabolite; mouse metabolite; thyroid hormone |
diphenyl | [no description available] | medium | 4 | 0 | aromatic fungicide; benzenes; biphenyls | antifungal agrochemical; antimicrobial food preservative |
3,3',5'-triiodothyronine | [no description available] | medium | 2 | 0 | iodothyronine | human metabolite |
2,2',6,6'-tetrachlorobiphenyl | [no description available] | medium | 3 | 0 | ||
3,4,5,3',4',5'-hexachlorobiphenyl | [no description available] | medium | 3 | 0 | hexachlorobiphenyl; trichlorobenzene | |
kc 400 | [no description available] | medium | 3 | 0 | dichlorobenzene; tetrachlorobiphenyl | |
4-hydroxy-2',4',6'-trichlorobiphenyl | [no description available] | medium | 2 | 0 | biphenyls; trichlorobenzene | |
4-hydroxy-2',3',4'-5'-tetrachlorobiphenyl | [no description available] | medium | 3 | 0 | biphenyls; tetrachlorobenzene | |
2,4,6-triiodophenol | [no description available] | medium | 2 | 0 | ||
2,3,7,8-tetrachlorodibenzodioxine | [no description available] | medium | 1 | 0 | polychlorinated dibenzodioxine | |
chlordecone | [no description available] | medium | 1 | 0 | cyclic ketone; organochlorine compound | insecticide; persistent organic pollutant |
hexachlorocyclohexane | [no description available] | medium | 1 | 0 | chlorocyclohexane | |
vanillin | [no description available] | medium | 1 | 0 | benzaldehydes; monomethoxybenzene; phenols | anti-inflammatory agent; anticonvulsant; antioxidant; flavouring agent; plant metabolite |
2,4,5-trichlorophenoxyacetic acid | [no description available] | medium | 1 | 0 | chlorophenoxyacetic acid; trichlorobenzene | defoliant; phenoxy herbicide; synthetic auxin |
4-nonylphenol | [no description available] | medium | 1 | 0 | phenols | environmental contaminant |
clomiphene | [no description available] | medium | 1 | 0 | tertiary amine | estrogen antagonist; estrogen receptor modulator |
dichlorodiphenyl dichloroethylene | [no description available] | medium | 1 | 0 | chlorophenylethylene; monochlorobenzenes | human xenobiotic metabolite; persistent organic pollutant |
ddt | [no description available] | medium | 1 | 0 | benzenoid aromatic compound; chlorophenylethane; monochlorobenzenes; organochlorine insecticide | bridged diphenyl acaricide; carcinogenic agent; endocrine disruptor; persistent organic pollutant |
benzophenone | [no description available] | medium | 1 | 0 | benzophenones | photosensitizing agent; plant metabolite |
endosulfan | [no description available] | medium | 1 | 0 | cyclic sulfite ester; cyclodiene organochlorine insecticide | acaricide; agrochemical; GABA-gated chloride channel antagonist; persistent organic pollutant |
heptachlor | [no description available] | medium | 1 | 0 | cyclodiene organochlorine insecticide | agrochemical; antibacterial agent; antifungal agent; GABA-gated chloride channel antagonist; persistent organic pollutant |
methoxychlor | [no description available] | medium | 1 | 0 | organochlorine insecticide | |
nafoxidine | [no description available] | medium | 1 | 0 | benzenes; naphthalenes; ring assembly | |
corticosterone | [no description available] | medium | 1 | 0 | 11beta-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; C21-steroid; glucocorticoid; primary alpha-hydroxy ketone | human metabolite; mouse metabolite |
prednisolone | [no description available] | medium | 1 | 0 | 11beta-hydroxy steroid; 17alpha-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(1),Delta(4)-steroid; C21-steroid; glucocorticoid; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone | adrenergic agent; anti-inflammatory drug; antineoplastic agent; drug metabolite; environmental contaminant; immunosuppressive agent; xenobiotic |
estriol | [no description available] | medium | 1 | 0 | 16alpha-hydroxy steroid; 17beta-hydroxy steroid; 3-hydroxy steroid | estrogen; human metabolite; human xenobiotic metabolite; mouse metabolite |
spironolactone | [no description available] | medium | 1 | 0 | 3-oxo-Delta(4) steroid; oxaspiro compound; steroid lactone; thioester | aldosterone antagonist; antihypertensive agent; diuretic; environmental contaminant; xenobiotic |
aldosterone | [no description available] | medium | 1 | 0 | 11beta-hydroxy steroid; 18-oxo steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; C21-steroid hormone; mineralocorticoid; primary alpha-hydroxy ketone; steroid aldehyde | human metabolite; mouse metabolite |
androsterone | [no description available] | medium | 1 | 0 | 17-oxo steroid; 3alpha-hydroxy steroid; androstanoid; C19-steroid | androgen; anticonvulsant; human blood serum metabolite; human metabolite; human urinary metabolite; mouse metabolite; pheromone |
17-desoxyestradiol | [no description available] | medium | 1 | 0 | 3-hydroxy steroid; phenolic steroid; phenols | estrogen |
ethinyl estradiol | [no description available] | medium | 1 | 0 | 17-hydroxy steroid; 3-hydroxy steroid; terminal acetylenic compound | xenoestrogen |
chlordan | [no description available] | medium | 1 | 0 | cyclodiene organochlorine insecticide | GABA-gated chloride channel antagonist; persistent organic pollutant |
testosterone propionate | [no description available] | medium | 1 | 0 | steroid ester | |
methyltestosterone | [no description available] | medium | 1 | 0 | 17beta-hydroxy steroid; 3-oxo-Delta(4) steroid; enone | anabolic agent; androgen; antineoplastic agent |
androstenedione | [no description available] | medium | 1 | 0 | 17-oxo steroid; 3-oxo-Delta(4) steroid; androstanoid | androgen; Daphnia magna metabolite; human metabolite; mouse metabolite |
norethindrone | [no description available] | medium | 1 | 0 | 17beta-hydroxy steroid; 3-oxo-Delta(4) steroid; terminal acetylenic compound; tertiary alcohol | progestin; synthetic oral contraceptive |
norethynodrel | [no description available] | medium | 1 | 0 | oxo steroid | |
medroxyprogesterone acetate | [no description available] | medium | 1 | 0 | 20-oxo steroid; 3-oxo-Delta(4) steroid; acetate ester; corticosteroid; steroid ester | adjuvant; androgen; antineoplastic agent; antioxidant; female contraceptive drug; inhibitor; progestin; synthetic oral contraceptive |
dichlorodiphenyldichloroethane | [no description available] | medium | 1 | 0 | chlorophenylethane; monochlorobenzenes; organochlorine insecticide | xenobiotic metabolite |
bisphenol a | [no description available] | medium | 1 | 0 | bisphenol | endocrine disruptor; environmental contaminant; xenobiotic; xenoestrogen |
p-tert-amylphenol | [no description available] | medium | 1 | 0 | alkylbenzene | |
2-sec-butylphenol | [no description available] | medium | 1 | 0 | phenols | |
4-phenylphenol | [no description available] | medium | 2 | 0 | hydroxybiphenyls | |
propylparaben | [no description available] | medium | 1 | 0 | benzoate ester; paraben; phenols | antifungal agent; antimicrobial agent |
butylphen | [no description available] | medium | 1 | 0 | phenols | allergen |
methylparaben | [no description available] | medium | 1 | 0 | paraben | antifungal agent; antimicrobial food preservative; neuroprotective agent; plant metabolite |
monobenzone | [no description available] | medium | 1 | 0 | benzyl ether | allergen; dermatologic drug; melanin synthesis inhibitor |
3-chlorophenol | [no description available] | medium | 1 | 0 | monochlorophenol | |
2,4-dihydroxybenzophenone | [no description available] | medium | 1 | 0 | benzophenones | |
cyproterone acetate | [no description available] | medium | 1 | 0 | 20-oxo steroid; 3-oxo-Delta(4) steroid; acetate ester; chlorinated steroid; steroid ester | androgen antagonist; geroprotector; progestin |
epitestosterone | [no description available] | medium | 1 | 0 | 17alpha-hydroxy steroid; 3-oxo-Delta(4) steroid; androstanoid | androgen antagonist; human metabolite |
flavanone | [no description available] | medium | 1 | 0 | flavanones | |
androstenediol | [no description available] | medium | 1 | 0 | 17beta-hydroxy steroid; 3beta-hydroxy-Delta(5)-steroid | androgen; human metabolite; mouse metabolite; radiation protective agent |
dihydrotestosterone | [no description available] | medium | 1 | 0 | 17beta-hydroxy steroid; 17beta-hydroxyandrostan-3-one; 3-oxo-5alpha-steroid | androgen; Daphnia magna metabolite; human metabolite; mouse metabolite |
flavone | [no description available] | medium | 1 | 0 | flavones | metabolite; nematicide |
4-cumylphenol | [no description available] | medium | 2 | 0 | diarylmethane | |
o,p'-ddt | [no description available] | medium | 1 | 0 | diarylmethane | |
4-hydroxybenzophenone | [no description available] | medium | 1 | 0 | benzophenones | |
4-chloro-2-cresol | [no description available] | medium | 1 | 0 | monochlorobenzenes; phenols | |
4-octylphenol | [no description available] | medium | 1 | 0 | phenols | metabolite; surfactant; xenoestrogen |
2,4,2',4'-tetrachlorobiphenyl | [no description available] | medium | 1 | 0 | dichlorobenzene; tetrachlorobiphenyl | |
ac 45594 | [no description available] | medium | 1 | 0 | aromatic ether | |
promegestone | [no description available] | medium | 1 | 0 | 20-oxo steroid; 3-oxo-Delta(4) steroid | antineoplastic agent; progesterone receptor agonist; progestin |
2,4'-dichlorobiphenyl | [no description available] | medium | 1 | 0 | dichlorobiphenyl; monochlorobenzenes | |
4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol | [no description available] | medium | 1 | 0 | stilbenoid | |
taleranol | [no description available] | medium | 1 | 0 | macrolide | |
bisphenol b | [no description available] | medium | 1 | 0 | bisphenol | |
alfatradiol | [no description available] | medium | 1 | 0 | 17alpha-hydroxy steroid; 3-hydroxy steroid; estradiol | estrogen; geroprotector |
4,4'-Dihydroxybenzophenone | [no description available] | medium | 1 | 0 | benzophenones | |
6-hydroxyflavone | [no description available] | medium | 1 | 0 | hydroxyflavonoid | |
2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane | [no description available] | medium | 2 | 0 | bisphenol | |
1,1-Dichloro-2,2-bis(4-hydroxyphenyl)ethylene | [no description available] | medium | 1 | 0 | diarylmethane | |
equol | [no description available] | medium | 1 | 0 | hydroxyisoflavans | |
androstan-3-ol | [no description available] | medium | 1 | 0 | 3-hydroxy steroid | androgen |
3,3'-Dihydroxyhexestrol | [no description available] | medium | 1 | 0 | stilbenoid | |
Zearalanone | [no description available] | medium | 1 | 0 | macrolide; resorcinols | |
4-androstene-3,17-diol | [no description available] | medium | 1 | 0 | 3-hydroxy steroid | androgen |
4'-hydroxyflavanone | [no description available] | medium | 1 | 0 | 4'-hydroxyflavanones; monohydroxyflavanone | |
2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene | [no description available] | medium | 1 | 0 | diarylmethane | |
2-hydroxyestradiol | [no description available] | medium | 1 | 0 | 17beta-hydroxy steroid; 2-hydroxy steroid | carcinogenic agent; human metabolite; metabolite; mouse metabolite; prodrug |
mibolerone | [no description available] | medium | 1 | 0 | 17beta-hydroxy steroid; 3-oxo-Delta(4) steroid | anabolic agent; androgen |
metribolone | [no description available] | medium | 1 | 0 | 17beta-hydroxy steroid; 3-oxo steroid; anabolic androgenic steroid | androgen |
diethylstilbestrol | [no description available] | medium | 2 | 0 | olefinic compound; polyphenol | antifungal agent; antineoplastic agent; autophagy inducer; calcium channel blocker; carcinogenic agent; EC 1.1.1.146 (11beta-hydroxysteroid dehydrogenase) inhibitor; EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor; endocrine disruptor; xenoestrogen |
chalcone | [no description available] | medium | 1 | 0 | chalcone | EC 3.2.1.1 (alpha-amylase) inhibitor |
isoeugenol | [no description available] | medium | 1 | 0 | isoeugenol | |
tamoxifen | [no description available] | medium | 1 | 0 | stilbenoid; tertiary amino compound | angiogenesis inhibitor; antineoplastic agent; bone density conservation agent; EC 1.2.3.1 (aldehyde oxidase) inhibitor; EC 2.7.11.13 (protein kinase C) inhibitor; estrogen antagonist; estrogen receptor antagonist; estrogen receptor modulator |
6-hydroxyflavanone | [no description available] | medium | 1 | 0 | monohydroxyflavanone | fungal xenobiotic metabolite |
dimethylstilbestrol | [no description available] | medium | 1 | 0 | stilbenoid | |
genistein | [no description available] | medium | 1 | 0 | 7-hydroxyisoflavones | antineoplastic agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; geroprotector; human urinary metabolite; phytoestrogen; plant metabolite; tyrosine kinase inhibitor |
coumestrol | [no description available] | medium | 1 | 0 | coumestans; delta-lactone; polyphenol | anti-inflammatory agent; antioxidant; plant metabolite |
7-hydroxyflavone | [no description available] | medium | 1 | 0 | hydroxyflavonoid | |
4-hydroxyestradiol | [no description available] | medium | 1 | 0 | 4-hydroxy steroid | metabolite |
4-hydroxychalcone | [no description available] | medium | 1 | 0 | chalcones; phenols | antihypertensive agent; plant metabolite |
4'-hydroxychalcone | [no description available] | medium | 1 | 0 | chalcones; phenols | anti-inflammatory agent; antineoplastic agent |
4,4'-dihydroxystilbene | [no description available] | medium | 1 | 0 | stilbene-4,4'-diol | |
4-hydroxystilbene | [no description available] | medium | 2 | 0 | stilben-4-ol | |
2,4-dinitrophenol | [no description available] | medium | 1 | 0 | dinitrophenol | allergen; antiseptic drug; bacterial xenobiotic metabolite; geroprotector; oxidative phosphorylation inhibitor |
diclofenac | [no description available] | medium | 1 | 0 | amino acid; aromatic amine; dichlorobenzene; monocarboxylic acid; secondary amino compound | antipyretic; drug allergen; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; environmental contaminant; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic |
diflunisal | [no description available] | medium | 2 | 0 | monohydroxybenzoic acid; organofluorine compound | non-narcotic analgesic; non-steroidal anti-inflammatory drug |
flufenamic acid | [no description available] | medium | 2 | 0 | aromatic amino acid; organofluorine compound | antipyretic; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug |
flurbiprofen | [no description available] | medium | 1 | 0 | fluorobiphenyl; monocarboxylic acid | antipyretic; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug |
tetraiodothyroacetic acid | [no description available] | medium | 1 | 0 | 2-halophenol; aromatic ether; iodophenol; monocarboxylic acid | apoptosis inducer; human metabolite; thyroid hormone |
tretinoin | [no description available] | medium | 1 | 0 | retinoic acid; vitamin A | anti-inflammatory agent; antineoplastic agent; antioxidant; AP-1 antagonist; human metabolite; keratolytic drug; retinoic acid receptor agonist; retinoid X receptor agonist; signalling molecule |
resveratrol | [no description available] | medium | 2 | 0 | resveratrol | antioxidant; phytoalexin; plant metabolite; quorum sensing inhibitor; radical scavenger |
iododiflunisal | [no description available] | medium | 2 | 0 | ||
tafamidis | [no description available] | medium | 2 | 0 | 1,3-benzoxazoles; dichlorobenzene; monocarboxylic acid | central nervous system drug |
idarucizumab | [no description available] | medium | 1 | 0 | ||
meclofenamic acid | [no description available] | medium | 1 | 0 | aminobenzoic acid; organochlorine compound; secondary amino compound | analgesic; anticonvulsant; antineoplastic agent; antipyretic; antirheumatic drug; EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-steroidal anti-inflammatory drug |
mefenamic acid | [no description available] | medium | 1 | 0 | aminobenzoic acid; secondary amino compound | analgesic; antipyretic; antirheumatic drug; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; environmental contaminant; non-steroidal anti-inflammatory drug; xenobiotic |
4-nitrobiphenyl | [no description available] | medium | 1 | 0 | biphenyls | |
4-fluorobiphenyl | [no description available] | medium | 1 | 0 | ||
3-hydroxybiphenyl | [no description available] | medium | 1 | 0 | hydroxybiphenyls | |
biphenyl-3-carboxylic acid | [no description available] | medium | 1 | 0 | ||
3,5-dichlorobiphenyl | [no description available] | medium | 1 | 0 | dichlorobenzene; dichlorobiphenyl | |
4-phenylbenzoic acid | [no description available] | medium | 1 | 0 | ||
biphenyl-2-carboxylic acid | [no description available] | medium | 1 | 0 | ||
2-phenoxybenzoic acid | [no description available] | medium | 1 | 0 | phenoxybenzoic acid | |
dihydroresveratrol | [no description available] | medium | 1 | 0 | stilbenol | plant metabolite; xenobiotic metabolite |
ns 1652 | [no description available] | medium | 1 | 0 | ||
levoplast | [no description available] | medium | 1 | 0 | C-nitro compound | |
hippuric acid | [no description available] | medium | 1 | 0 | N-acylglycine | human blood serum metabolite; uremic toxin |
xanthine | [no description available] | medium | 1 | 0 | xanthine | Saccharomyces cerevisiae metabolite |
atrolactic acid | [no description available] | medium | 1 | 0 | 2-hydroxy monocarboxylic acid | |
etofylline | [no description available] | medium | 1 | 0 | oxopurine | |
n-acetyltryptophan | [no description available] | medium | 1 | 0 | N-acetyl-amino acid; tryptophan derivative | metabolite |
ethacridine | [no description available] | medium | 1 | 0 | acridines | |
altretamine | [no description available] | medium | 1 | 0 | triamino-1,3,5-triazine | |
2,5-di-tert-butylhydroquinone | [no description available] | medium | 1 | 0 | hydroquinones | |
cx546 | [no description available] | medium | 1 | 0 | ||
diphenhydramine | [no description available] | medium | 1 | 0 | ether; tertiary amino compound | anti-allergic agent; antidyskinesia agent; antiemetic; antiparkinson drug; antipruritic drug; antitussive; H1-receptor antagonist; local anaesthetic; muscarinic antagonist; oneirogen; sedative |
diuron | [no description available] | medium | 1 | 0 | 3-(3,4-substituted-phenyl)-1,1-dimethylurea; dichlorobenzene | environmental contaminant; mitochondrial respiratory-chain inhibitor; photosystem-II inhibitor; urea herbicide; xenobiotic |
ibuprofen | [no description available] | medium | 1 | 0 | monocarboxylic acid | antipyretic; cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor; drug allergen; environmental contaminant; geroprotector; non-narcotic analgesic; non-steroidal anti-inflammatory drug; radical scavenger; xenobiotic |
ipriflavone | [no description available] | medium | 1 | 0 | aromatic ether; isoflavones | bone density conservation agent |
mebendazole | [no description available] | medium | 1 | 0 | aromatic ketone; benzimidazoles; carbamate ester | antinematodal drug; microtubule-destabilising agent; tubulin modulator |
nocodazole | [no description available] | medium | 1 | 0 | aromatic ketone; benzimidazoles; carbamate ester; thiophenes | antimitotic; antineoplastic agent; microtubule-destabilising agent; tubulin modulator |
piribedil | [no description available] | medium | 1 | 0 | N-arylpiperazine | |
procainamide | [no description available] | medium | 1 | 0 | benzamides | anti-arrhythmia drug; platelet aggregation inhibitor; sodium channel blocker |
prometone | [no description available] | medium | 1 | 0 | diamino-1,3,5-triazine; methoxy-1,3,5-triazine | environmental contaminant; herbicide; xenobiotic |
propanil | [no description available] | medium | 1 | 0 | anilide; dichlorobenzene | herbicide |
sulfadimethoxine | [no description available] | medium | 1 | 0 | aromatic ether; pyrimidines; substituted aniline; sulfonamide antibiotic; sulfonamide | antiinfective agent; antimicrobial agent; drug allergen; environmental contaminant; xenobiotic |
sulfamethazine | [no description available] | medium | 1 | 0 | pyrimidines; sulfonamide antibiotic; sulfonamide | antibacterial drug; antiinfective agent; antimicrobial agent; carcinogenic agent; drug allergen; EC 2.5.1.15 (dihydropteroate synthase) inhibitor; environmental contaminant; ligand; xenobiotic |
sulfathiazole | [no description available] | medium | 1 | 0 | 1,3-thiazoles; substituted aniline; sulfonamide antibiotic; sulfonamide | antiinfective agent; drug allergen; EC 2.5.1.15 (dihydropteroate synthase) inhibitor; environmental contaminant; xenobiotic |
testosterone | [no description available] | medium | 1 | 0 | 3-hydroxy steroid | androgen |
2-hydroxybenzylbenzimidazole | [no description available] | medium | 1 | 0 | ||
etimizol | [no description available] | medium | 1 | 0 | ||
nifenalol | [no description available] | medium | 1 | 0 | C-nitro compound | |
bis(4-hydroxyphenyl)sulfone | [no description available] | medium | 1 | 0 | bisphenol; sulfone | endocrine disruptor; metabolite |
8-hydroxyquinoline-5-sulfonic acid | [no description available] | medium | 1 | 0 | ||
salicylanilide | [no description available] | medium | 1 | 0 | benzanilide fungicide; salicylamides; salicylanilides | |
2-phenylbutyric acid | [no description available] | medium | 1 | 0 | benzenes; monocarboxylic acid | human xenobiotic metabolite |
4,4'-dimethoxybenzophenone | [no description available] | medium | 1 | 0 | ||
6-phenyl-1,3,5-triazine-2,4-diamine | [no description available] | medium | 1 | 0 | ||
quinaldic acid | [no description available] | medium | 1 | 0 | quinolinemonocarboxylic acid | human metabolite; Saccharomyces cerevisiae metabolite |
N-(2-methoxyphenyl)acetamide | [no description available] | medium | 1 | 0 | acetamides; methoxybenzenes | |
fast red b | [no description available] | medium | 1 | 0 | ||
methylenebis(chloroaniline) | [no description available] | medium | 1 | 0 | chloroaniline | metabolite |
di-(4-aminophenyl)ether | [no description available] | medium | 1 | 0 | aromatic ether | |
diphenylguanidine | [no description available] | medium | 1 | 0 | guanidines | allergen |
4-Anilino-4-oxobutanoic acid | [no description available] | medium | 1 | 0 | anilide | |
mephobarbital | [no description available] | medium | 1 | 0 | barbiturates | anticonvulsant |
etryptamine | [no description available] | medium | 1 | 0 | indoles | |
sulfacetamide | [no description available] | medium | 1 | 0 | ||
cinchophen | [no description available] | medium | 1 | 0 | quinolines | |
2-aminobenzothiazole | [no description available] | medium | 1 | 0 | benzothiazoles | |
carzenide | [no description available] | medium | 1 | 0 | sulfonamide | |
nitrilotriacetic acid | [no description available] | medium | 1 | 0 | NTA; tricarboxylic acid | carcinogenic agent; nephrotoxic agent |
n-(2-cyanoethyl)-2-phenylethylamine | [no description available] | medium | 1 | 0 | ||
cyclooctane | [no description available] | medium | 1 | 0 | ||
triphenyltetrazolium chloride | [no description available] | medium | 1 | 0 | organic chloride salt | dye; indicator |
2,7-diacetylaminofluorene | [no description available] | medium | 1 | 0 | ||
3,4-pyridinedicarboxylic acid | [no description available] | medium | 1 | 0 | pyridinedicarboxylic acid | |
4-(benzoylamino)-2-hydroxybenzoic acid | [no description available] | medium | 1 | 0 | benzamides | |
tropic acid | [no description available] | medium | 1 | 0 | 3-hydroxy monocarboxylic acid | human xenobiotic metabolite |
8-hydroxy-7-iodo-5-quinolinesulfonic acid | [no description available] | medium | 1 | 0 | hydroxyquinoline | |
1-acetylisatin | [no description available] | medium | 1 | 0 | indoledione | |
5-methylisatin | [no description available] | medium | 1 | 0 | ||
2-hydrazinobenzothiazole | [no description available] | medium | 1 | 0 | ||
1,2,3-trimethoxybenzene | [no description available] | medium | 1 | 0 | methoxybenzenes | plant metabolite |
2-amino-5-chlorobenzophenone | [no description available] | medium | 1 | 0 | ||
diphenamid | [no description available] | medium | 1 | 0 | diarylmethane | |
4-(4-nitrobenzyl)pyridine | [no description available] | medium | 1 | 0 | ||
5-methyl-3-phenylisoxazole-4-carboxylic acid | [no description available] | medium | 1 | 0 | ||
2-acetylbenzofuran | [no description available] | medium | 1 | 0 | ||
pyrazon | [no description available] | medium | 1 | 0 | benzenes; organochlorine compound; primary amino compound; pyridazinone | environmental contaminant; herbicide; xenobiotic |
2-amino-5-nitrobenzophenone | [no description available] | medium | 1 | 0 | ||
(4-tert-Butyl-phenoxy)-acetic acid | [no description available] | medium | 1 | 0 | monocarboxylic acid | |
lenacil | [no description available] | medium | 1 | 0 | cyclopentapyrimidine | agrochemical; environmental contaminant; herbicide; xenobiotic |
chlordesmethyldiazepam | [no description available] | medium | 1 | 0 | benzodiazepine | |
2-amino-2',5-dichlorobenzophenone | [no description available] | medium | 1 | 0 | ||
2-(2'-hydroxyphenyl)benzimidazole | [no description available] | medium | 1 | 0 | ||
4-phthalimidobutyric acid | [no description available] | medium | 1 | 0 | ||
azabutyrone | [no description available] | medium | 1 | 0 | ||
2-(2-hydroxyphenyl)benzothiazole | [no description available] | medium | 1 | 0 | benzothiazoles; phenols | geroprotector |
4,5-dichlorocatechol | [no description available] | medium | 1 | 0 | ||
n-butylbenzenesulfonamide | [no description available] | medium | 1 | 0 | sulfonamide | neurotoxin; plant metabolite |
3-phenoxybenzoic acid | [no description available] | medium | 1 | 0 | phenoxybenzoic acid | human xenobiotic metabolite; marine xenobiotic metabolite |
2-(2-hydroxyethylmercapto)benzothiazole | [no description available] | medium | 1 | 0 | ||
carboxin | [no description available] | medium | 1 | 0 | anilide fungicide; anilide; enamide; organosulfur heterocyclic compound; oxacycle; secondary carboxamide | antifungal agrochemical; EC 1.3.5.1 [succinate dehydrogenase (quinone)] inhibitor |
meturin | [no description available] | medium | 1 | 0 | ||
2-bromo-N-phenylbenzamide | [no description available] | medium | 1 | 0 | benzamides | |
4-chlorohippuric acid | [no description available] | medium | 1 | 0 | ||
4-chlorophenoxyacetic acid | [no description available] | medium | 1 | 0 | chlorophenoxyacetic acid; monochlorobenzenes | phenoxy herbicide |
2,5-dichloro-1,4-phenylenediamine | [no description available] | medium | 1 | 0 | ||
metribuzin | [no description available] | medium | 1 | 0 | 1,2,4-triazines; cyclic ketone; organic sulfide | agrochemical; environmental contaminant; herbicide; xenobiotic |
2,5-dimethyl-3-furancarboxanilide | [no description available] | medium | 1 | 0 | ||
moricizine hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | anti-arrhythmia drug |
2-benzimidazolylguanidine | [no description available] | medium | 1 | 0 | aminoimidazole | |
diflubenzuron | [no description available] | medium | 1 | 0 | benzoylurea insecticide; monochlorobenzenes | insect sterilant |
pentafluorobenzoyl-n-phenylethylamine | [no description available] | medium | 1 | 0 | ||
thidiazuron | [no description available] | medium | 1 | 0 | ureas | |
phenthiazamine | [no description available] | medium | 1 | 0 | ||
5,5-diphenylbarbituric acid | [no description available] | medium | 1 | 0 | ||
3-acetamidobenzoic acid | [no description available] | medium | 1 | 0 | ||
dazoxiben hydrochloride | [no description available] | medium | 1 | 0 | ||
succinylsulfanilamide | [no description available] | medium | 1 | 0 | ||
benzylaminopurine | [no description available] | medium | 1 | 0 | 6-aminopurines | cytokinin; plant metabolite |
ciprofloxacin hydrochloride anhydrous | [no description available] | medium | 1 | 0 | hydrochloride | antibacterial drug; antiinfective agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; topoisomerase IV inhibitor |
src-820 r | [no description available] | medium | 1 | 0 | ||
n(4)-acetylsulfadiazine | [no description available] | medium | 1 | 0 | acetamides; pyrimidines; sulfonamide | marine xenobiotic metabolite |
4-nitro-alpha-acetylamino-beta-hydroxypropiophenone | [no description available] | medium | 1 | 0 | ||
formetamide | [no description available] | medium | 1 | 0 | ||
isbufylline | [no description available] | medium | 1 | 0 | ||
phenylacetylglycine | [no description available] | medium | 1 | 0 | monocarboxylic acid amide; monocarboxylic acid; N-acylglycine | human metabolite; mouse metabolite |
N-benzoylanthranilic acid | [no description available] | medium | 1 | 0 | amidobenzoic acid | |
butinoline | [no description available] | medium | 1 | 0 | diarylmethane | |
n-(2-carboxyphenyl)glycine | [no description available] | medium | 1 | 0 | ||
n,n-dimethyl-4-anisidine | [no description available] | medium | 1 | 0 | ||
n-benzoylpiperidine | [no description available] | medium | 1 | 0 | benzamides; N-acylpiperidine | |
2-phenylcyclopropanecarboxylic acid | [no description available] | medium | 1 | 0 | ||
n-demethylantipyrine | [no description available] | medium | 1 | 0 | pyrazoles; ring assembly | |
3-(2-pyridyl)-5,6-diphenyl-1,2,4-triazine | [no description available] | medium | 1 | 0 | 1,2,4-triazines | |
2-amino-5-bromopyridine | [no description available] | medium | 1 | 0 | ||
n-benzoylalanine, (dl-ala)-isomer | [no description available] | medium | 1 | 0 | alanine derivative; N-acyl-amino acid | metabolite |
bicinchoninic acid | [no description available] | medium | 1 | 0 | ||
betamipron | [no description available] | medium | 1 | 0 | organonitrogen compound; organooxygen compound | |
benzoylpropionic acid | [no description available] | medium | 1 | 0 | 4-oxo monocarboxylic acid | hapten |
Evoxine | [no description available] | medium | 1 | 0 | organic heterotricyclic compound; organonitrogen heterocyclic compound; oxacycle | |
1-methyl-1,2,3,4-tetrahydro-beta-carboline-3-carboxylic acid | [no description available] | medium | 1 | 0 | harmala alkaloid | |
N-Benzylphthalimide | [no description available] | medium | 1 | 0 | isoindoles | |
pyromellitic diimide | [no description available] | medium | 1 | 0 | ||
4'-bromosalicylanilide | [no description available] | medium | 1 | 0 | ||
terephthalamide | [no description available] | medium | 1 | 0 | benzenedicarboxamide | |
3(2h)-pyridazinone, 4-chloro-5-(dimethylamino)-2-phenyl- | [no description available] | medium | 1 | 0 | ||
2-nitrophenylacetic acid | [no description available] | medium | 1 | 0 | C-nitro compound; phenylacetic acids | |
onychine | [no description available] | medium | 1 | 0 | ||
4'-methoxyflavone | [no description available] | medium | 1 | 0 | ether; flavonoids | |
1,3-diphenyl-2-aminopropane | [no description available] | medium | 1 | 0 | ||
2,2-diphenylpropionic acid | [no description available] | medium | 1 | 0 | ||
3,4-dimethoxyphenylacetamide | [no description available] | medium | 1 | 0 | ||
2-amino-5-bromobenzoic acid | [no description available] | medium | 1 | 0 | ||
2-(1H-benzimidazol-2-yl)aniline | [no description available] | medium | 1 | 0 | benzimidazoles; primary arylamine; substituted aniline | geroprotector |
N-Acetylhomoveratrylamine | [no description available] | medium | 1 | 0 | acetamides | |
2-chlorobenzenesulfonamide | [no description available] | medium | 1 | 0 | ||
4-nitrophenyl dimethylcarbamate | [no description available] | medium | 1 | 0 | ||
8-(4-tolylsulfonylamino)quinoline | [no description available] | medium | 1 | 0 | sulfonamide | |
5-methoxyindole-3-carbaldehyde | [no description available] | medium | 1 | 0 | indoles | |
2-oxo-1,2-dihydroquinoline-4-carboxylic acid | [no description available] | medium | 1 | 0 | quinolinemonocarboxylic acid | |
6-methoxy-2,3,4,9-tetrahydropyrido[3,4-b]indol-1-one | [no description available] | medium | 1 | 0 | beta-carbolines | |
pd 147953 | [no description available] | medium | 1 | 0 | ||
fenozan | [no description available] | medium | 1 | 0 | ||
5-phenylbarbituric acid | [no description available] | medium | 1 | 0 | ||
diethylpropion hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | appetite depressant |
1-(4'-nitrophenyl)-2-aminopropane-1,3-diol | [no description available] | medium | 1 | 0 | ||
beta-hydroxyphenylalanine | [no description available] | medium | 1 | 0 | ||
3-(n-salicyloyl)amino-1,2,4-triazole | [no description available] | medium | 1 | 0 | ||
7-chloro-4-aminoquinoline | [no description available] | medium | 1 | 0 | aminoquinoline | |
acridine-9-carboxylic acid | [no description available] | medium | 1 | 0 | ||
1-phenazinecarboxylic acid | [no description available] | medium | 1 | 0 | aromatic carboxylic acid; monocarboxylic acid; phenazines | antifungal agent; antimicrobial agent; bacterial metabolite |
4,5-diphenyl-1,5-dihydroimidazol-2-one | [no description available] | medium | 1 | 0 | stilbenoid | |
2-hydroxy-1,2-bis(methoxyphenyl)ethanone | [no description available] | medium | 1 | 0 | ||
4-methyl-N-(phenylmethyl)benzenesulfonamide | [no description available] | medium | 1 | 0 | sulfonamide | |
4-n-butylaminobenzoic acid | [no description available] | medium | 1 | 0 | aromatic amino acid | |
fluoren-9-ol | [no description available] | medium | 1 | 0 | ||
1-(2-carboxyethyl)uracil | [no description available] | medium | 1 | 0 | ||
1-benzylindole | [no description available] | medium | 1 | 0 | ||
2,3-bis(2-pyridinyl)quinoxaline | [no description available] | medium | 1 | 0 | quinoxaline derivative | |
5-nitro-2-(1-piperidinyl)pyridine | [no description available] | medium | 1 | 0 | C-nitro compound | |
2-amino-5,7-dimethyl-1,8-naphthyridine | [no description available] | medium | 1 | 0 | ||
5-benzyloxytryptophan | [no description available] | medium | 1 | 0 | ||
2,5-diethoxy-4-morpholinoaniline | [no description available] | medium | 1 | 0 | ||
3-hydroxy-3-phenacyloxindole | [no description available] | medium | 1 | 0 | ||
carbobenzoxyphenylalanine, (dl-phe)-isomer | [no description available] | medium | 1 | 0 | ||
gamma-fagarine | [no description available] | medium | 1 | 0 | organic heterotricyclic compound; organonitrogen heterocyclic compound; oxacycle | |
3-carboxymethyl-6-benzyl-2,5-diketopiperazine | [no description available] | medium | 1 | 0 | organonitrogen compound; organooxygen compound | |
4-fluorobenzenesulfonamide | [no description available] | medium | 1 | 0 | ||
emoxypine succinate | [no description available] | medium | 1 | 0 | ||
n-carbamyltryptophan | [no description available] | medium | 1 | 0 | ||
2,4,6-trimethoxyacetophenone | [no description available] | medium | 1 | 0 | ||
1-(2-hydroxyethyl)-3,5-diphenyl-1h-pyrazole | [no description available] | medium | 1 | 0 | ||
4-methyoxybenzoyl-n-glycine | [no description available] | medium | 1 | 0 | N-acylglycine | |
5-ethoxy-2-ethylmercaptobenzimidazole | [no description available] | medium | 1 | 0 | ||
5(6)-1(2h)-phthalazinonyl-4(1h)-benzimidazole-2-carbamate methyl ester | [no description available] | medium | 1 | 0 | ||
n-phenyliminodiacetic acid | [no description available] | medium | 1 | 0 | ||
teomorfolin | [no description available] | medium | 1 | 0 | ||
1-(1,3-benzodioxol-5-yl)-3-(1-piperidinyl)-1-propanone | [no description available] | medium | 1 | 0 | benzodioxoles | |
n-(aminocarbonyl)-2-chlorobenzenesulfonamide | [no description available] | medium | 1 | 0 | ||
3-hydroxy-2-quinoxalinepropionic acid | [no description available] | medium | 1 | 0 | ||
8-(methylsulfonylamino)quinoline | [no description available] | medium | 1 | 0 | ||
n(4)-acetylsulfamonomethoxine | [no description available] | medium | 1 | 0 | ||
8-(4-benzenesulfonylamino)quinoline | [no description available] | medium | 1 | 0 | ||
methindione | [no description available] | medium | 1 | 0 | ||
3,4-dihydroxybenzophenone | [no description available] | medium | 1 | 0 | ||
gamma-propanol | [no description available] | medium | 1 | 0 | ||
2-[(3-oxo-1-cyclohexenyl)amino]benzonitrile | [no description available] | medium | 1 | 0 | benzenes; nitrile | |
isonicotinylamide gaba | [no description available] | medium | 1 | 0 | ||
5-fluorotryptamine monohydrochloride | [no description available] | medium | 1 | 0 | ||
4-iodo-n-(2-(4-morpholinyl)ethyl)benzamide | [no description available] | medium | 1 | 0 | ||
3-(hydroxyacetyl)indole | [no description available] | medium | 1 | 0 | indoles | |
n-(4-aminophenylsulfonyl)morpholine | [no description available] | medium | 1 | 0 | ||
1H-indol-3-yl-(4-methoxyphenyl)methanone | [no description available] | medium | 1 | 0 | N-acylindole | |
2-amino-5-phenyl-1,3,4-thiadiazole | [no description available] | medium | 1 | 0 | ||
N-(1-phenylethyl)acetamide | [no description available] | medium | 1 | 0 | acetamides; secondary carboxamide | |
alpha-(trichloromethyl)-4-pyridineethanol | [no description available] | medium | 1 | 0 | pyridines | |
ml 204 | [no description available] | medium | 1 | 0 | ||
eudesmin | [no description available] | medium | 1 | 0 | ||
2-amino-4-methyl-3-nitropyridine | [no description available] | medium | 1 | 0 | ||
4,4-bis(hydroxymethyl)-2-phenyl-2-oxazoline | [no description available] | medium | 1 | 0 | ||
n-acetylhistidine | [no description available] | medium | 1 | 0 | histidine derivative; N-acetyl-amino acid | |
1-(1-oxo-2-phenylethyl)-4-piperidinecarboxylic acid | [no description available] | medium | 1 | 0 | acetamides | |
1-(4-chlorophenyl)-3-(2-ethoxyphenyl)urea | [no description available] | medium | 1 | 0 | ureas | |
4-methoxyxanthone | [no description available] | medium | 1 | 0 | ||
N-(4-nitrophenyl)-2-phenoxyacetamide | [no description available] | medium | 1 | 0 | C-nitro compound | |
1-phenylindolin-2-one | [no description available] | medium | 1 | 0 | ||
1-(benzenesulfonyl)indole | [no description available] | medium | 1 | 0 | sulfonamide | |
2,4,4,6-Tetramethyl-1,4-dihydro-3,5-pyridinedicarbonitrile | [no description available] | medium | 1 | 0 | dihydropyridine | |
pifithrin mu | [no description available] | medium | 1 | 0 | benzenes | |
2-benzyloxybenzaldehyde | [no description available] | medium | 1 | 0 | ||
2-guanidine-4-methylquinazoline | [no description available] | medium | 1 | 0 | ||
N-phenylcarbamic acid 2-phenoxyethyl ester | [no description available] | medium | 1 | 0 | carbamate ester | |
3,4-dihydro-2H-benzo[4,5]imidazo[2,1-b][1,3]thiazin-3-ol | [no description available] | medium | 1 | 0 | benzimidazoles | |
mequindox | [no description available] | medium | 1 | 0 | ||
N-[2-(dimethylamino)ethyl]-2,2-diphenylacetamide | [no description available] | medium | 1 | 0 | diarylmethane | |
Girgensonine | [no description available] | medium | 1 | 0 | nitrile | |
Dubinidine | [no description available] | medium | 1 | 0 | organic heterotricyclic compound; organonitrogen heterocyclic compound; oxacycle | |
N-[4-(methanesulfonamido)phenyl]acetamide | [no description available] | medium | 1 | 0 | sulfonamide | |
4-(2-oxazolo[4,5-b]pyridinyl)aniline | [no description available] | medium | 1 | 0 | 1,3-oxazoles | |
2-[(4-nitrophenyl)methylthio]-1,3-benzoxazole | [no description available] | medium | 1 | 0 | benzoxazole | |
3-oxido-4,5-dihydro-[1,2,5]oxadiazolo[3,4-f]cinnolin-3-ium | [no description available] | medium | 1 | 0 | pyridazines | |
3-(2,4-difluoroanilino)-5,5-dimethyl-1-cyclohex-2-enone | [no description available] | medium | 1 | 0 | substituted aniline | |
1-phenyl-4-pyrazolol | [no description available] | medium | 1 | 0 | pyrazoles; ring assembly | |
3-(3,5-dimethyl-1-pyrazolyl)-1,2-benzothiazole 1,1-dioxide | [no description available] | medium | 1 | 0 | benzothiazoles | |
3-benzamido-2-benzofurancarboxamide | [no description available] | medium | 1 | 0 | benzofurans | |
N-[2-(4-methoxyphenyl)ethyl]acetamide | [no description available] | medium | 1 | 0 | acetamides | |
N-[2-(3-methylphenoxy)ethyl]-1H-1,2,4-triazole-5-carboxamide | [no description available] | medium | 1 | 0 | aromatic ether | |
2-(1H-indol-3-ylthio)acetic acid | [no description available] | medium | 1 | 0 | indoles | |
3-bromo-N-[2-(4-nitroanilino)ethyl]benzamide | [no description available] | medium | 1 | 0 | carbonyl compound; organohalogen compound | |
3-Methylbenzofuran-2-carboxylic acid | [no description available] | medium | 1 | 0 | benzofurans | |
5-(3,4-dimethoxyphenyl)-2H-tetrazole | [no description available] | medium | 1 | 0 | tetrazoles | |
1-(4-fluorophenyl)sulfonyl-4-(2-methoxyphenyl)piperazine | [no description available] | medium | 1 | 0 | piperazines | |
4-[[bis(2-hydroxyethyl)amino]methyl]-2,6-ditert-butylphenol | [no description available] | medium | 1 | 0 | alkylbenzene | |
2-phenylindole-3-carbaldehyde | [no description available] | medium | 1 | 0 | ||
4-(2-pyridinylthio)benzofuro[3,2-d]pyrimidine | [no description available] | medium | 1 | 0 | aryl sulfide | |
5-(4-nitrophenyl)-4-phenyl-2-thiazolamine | [no description available] | medium | 1 | 0 | C-nitro compound | |
3-[6-(4-aminophenyl)-2-phenyl-4-pyrimidinyl]aniline | [no description available] | medium | 1 | 0 | pyrimidines | |
7-methoxyisoflavone | [no description available] | medium | 1 | 0 | 7-methoxyisoflavones | |
LSM-32392 | [no description available] | medium | 1 | 0 | monoterpenoid | |
N-[2-(1-cyclohexenyl)ethyl]-4-(4-morpholinylmethyl)benzamide | [no description available] | medium | 1 | 0 | benzamides | |
1-(1-benzimidazolyl)-3-(1-cyclohex-3-enylmethoxy)-2-propanol | [no description available] | medium | 1 | 0 | benzimidazoles | |
N-[2-(2-furanylmethylthio)ethyl]-4-methoxybenzenesulfonamide | [no description available] | medium | 1 | 0 | sulfonamide | |
3-acetamido-5-chloro-2-benzofurancarboxylic acid | [no description available] | medium | 1 | 0 | benzofurans | |
[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]-(2,6-dimethoxyphenyl)methanone | [no description available] | medium | 1 | 0 | dimethoxybenzene | |
4-[4-methyl-6-(4-methyl-1-piperazinyl)-2-pyrimidinyl]morpholine | [no description available] | medium | 1 | 0 | N-arylpiperazine | |
haplamine | [no description available] | medium | 1 | 0 | organic heterotricyclic compound; organonitrogen heterocyclic compound; oxacycle | |
5-(3,4-dimethoxyphenyl)-1H-1,2,4-triazol-3-amine | [no description available] | medium | 1 | 0 | triazoles | |
2-ethoxy-N-[4-(4-morpholinylsulfonyl)phenyl]benzamide | [no description available] | medium | 1 | 0 | benzamides | |
2-[(5-methyl-1H-1,2,4-triazol-3-yl)thio]-1-phenylethanone | [no description available] | medium | 1 | 0 | aromatic ketone | |
1-ethyl-6-methoxy-4-oxo-3-quinolinecarboxylic acid | [no description available] | medium | 1 | 0 | quinolines | |
2-(pyridin-4-yl)-4-(pyrrolidin-1-yl)quinazoline | [no description available] | medium | 1 | 0 | pyridines; pyrrolidines; quinazolines | |
scp 1 | [no description available] | medium | 1 | 0 | ||
N-(3-acetamidophenyl)-4-methoxybenzamide | [no description available] | medium | 1 | 0 | benzamides | |
N-(3-acetamidophenyl)-3-chlorobenzamide | [no description available] | medium | 1 | 0 | benzamides | |
4-methoxy-N-(5-methyl-3-isoxazolyl)benzamide | [no description available] | medium | 1 | 0 | benzamides | |
N-(2-fluorophenyl)-4-phenylmethoxybenzamide | [no description available] | medium | 1 | 0 | benzamides | |
N-[4-(diethylamino)phenyl]-2-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; furans | |
N-(2-furanylmethyl)-2-benzofurancarboxamide | [no description available] | medium | 1 | 0 | benzofurans | |
5-(2-phenylethyl)-1,3,4-thiadiazol-2-amine | [no description available] | medium | 1 | 0 | aromatic amine; thiadiazoles | |
te 5 | [no description available] | medium | 1 | 0 | ||
2-[[anilino(oxo)methyl]amino]-4,5-dimethyl-3-thiophenecarboxamide | [no description available] | medium | 1 | 0 | ureas | |
N-(4,6-dimethyl-2-pyrimidinyl)-1,3-benzothiazol-2-amine | [no description available] | medium | 1 | 0 | benzothiazoles | |
6-methylflavone | [no description available] | medium | 1 | 0 | ||
2-methoxy-N-(2-pyridinyl)benzamide | [no description available] | medium | 1 | 0 | benzamides | |
2-chloro-N-(2-phenylethyl)benzamide | [no description available] | medium | 1 | 0 | carbonyl compound; organohalogen compound | |
N1-(4H-1,2,4-triazol-4-yl)-4-nitrobenzamide | [no description available] | medium | 1 | 0 | C-nitro compound | |
N-[2-(1-cyclohexenyl)ethyl]-4-fluorobenzamide | [no description available] | medium | 1 | 0 | carbonyl compound; organohalogen compound | |
tioxazafen | [no description available] | medium | 1 | 0 | 1,2,4-oxadiazole; thiophenes | agrochemical; nematicide |
N-[5-(2-methylpropyl)-1,3,4-thiadiazol-2-yl]-2-thiophen-2-ylacetamide | [no description available] | medium | 1 | 0 | aromatic amide | |
1-(4-Methoxyphenyl)-2-nitroethylene | [no description available] | medium | 1 | 0 | methoxybenzenes | |
brd32048 | [no description available] | medium | 1 | 0 | methoxybenzenes; substituted aniline | |
2-(4-chloro-3-methylphenoxy)-N-(1H-1,2,4-triazol-5-yl)acetamide | [no description available] | medium | 1 | 0 | aromatic ether | |
2-(3,4-dichlorophenyl)imidazo[1,2-a]pyrimidine | [no description available] | medium | 1 | 0 | imidazoles | |
5-(2-phenyl-4-triazolyl)-2H-tetrazole | [no description available] | medium | 1 | 0 | triazoles | |
N-cyclohexyl-2,3-dihydroindole-1-carboxamide | [no description available] | medium | 1 | 0 | indolyl carboxylic acid | |
4-(benzylsulfanyl)thieno[2,3-d]pyrimidine | [no description available] | medium | 1 | 0 | aryl sulfide; benzenes; thienopyrimidine | |
2-methyl-5-(5-methyl-2-furanyl)-3-(1-pyrrolyl)-4-thieno[2,3-d]pyrimidinone | [no description available] | medium | 1 | 0 | organic heterobicyclic compound; organonitrogen heterocyclic compound; organosulfur heterocyclic compound | |
1-[2-(dimethylamino)ethyl]-5-methoxy-N-methyl-2-indolecarboxamide | [no description available] | medium | 1 | 0 | indolecarboxamide | |
N-(5-ethyl-1,3,4-thiadiazol-2-yl)-3-methoxybenzamide | [no description available] | medium | 1 | 0 | benzamides | |
4-(1H-benzimidazol-2-yl)quinoline | [no description available] | medium | 1 | 0 | quinolines | |
1-(4-Chlorophenyl)-2-[(1-methyl-1H-imidazol-2-yl)thio]ethan-1-one | [no description available] | medium | 1 | 0 | aromatic ketone | |
N-(2,5-dimethylphenyl)-2-benzofurancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; furans | |
N-(4-methoxyphenyl)-2-benzofurancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; furans | |
2-(9h-xanthen-9-yl)-malonic acid | [no description available] | medium | 1 | 0 | xanthenes | |
1-(1,3-benzothiazol-2-yl)-3-phenylurea | [no description available] | medium | 1 | 0 | ureas | |
1-hydroxy-2-phenyl-1,5,6,7-tetrahydro-4H-benzimidazol-4-one | [no description available] | medium | 1 | 0 | imidazoles | |
N-(4-acetamidophenyl)-2-bromobenzamide | [no description available] | medium | 1 | 0 | benzamides | |
4-bromo-N-phenacylbenzamide | [no description available] | medium | 1 | 0 | aromatic ketone | |
1-(2,3-dihydroindol-1-yl)-2-(phenylthio)ethanone | [no description available] | medium | 1 | 0 | indoles | |
N-[6-methyl-2-(4-methylphenyl)-5-benzotriazolyl]-3-pyridinecarboxamide | [no description available] | medium | 1 | 0 | triazoles | |
N,N-dimethyl-N'-p-tolylsulfamide | [no description available] | medium | 1 | 0 | sulfamides | marine xenobiotic metabolite |
2-(1-piperidinylmethyl)phenol | [no description available] | medium | 1 | 0 | ||
2,6-bis(benzimidazol-2-yl)pyridine | [no description available] | medium | 1 | 0 | benzimidazoles | |
1-cyclohexyl-3-(2-phenylethyl)urea | [no description available] | medium | 1 | 0 | benzenes | |
1-(3,5-dichlorophenyl)-3-phenylurea | [no description available] | medium | 1 | 0 | ureas | |
1-(cyclohexylmethyl)-4-phenylpiperazine | [no description available] | medium | 1 | 0 | piperazines | |
N-phenethyl-2-furamide | [no description available] | medium | 1 | 0 | aromatic amide; heteroarene | |
paromomycin sulfate | [no description available] | medium | 1 | 0 | ||
N,N,2-trimethyl-1-phenyl-5-benzimidazolesulfonamide | [no description available] | medium | 1 | 0 | benzimidazoles | |
N-(phenylmethyl)-4-(3-pyridinyl)-2-thiazolamine | [no description available] | medium | 1 | 0 | aralkylamine | |
N-(4-hydroxy-2-methyl-5-propan-2-ylphenyl)benzenesulfonamide | [no description available] | medium | 1 | 0 | monoterpenoid | |
2-amino-5-ethyl-4-(2-furanyl)-6-propyl-3-pyridinecarbonitrile | [no description available] | medium | 1 | 0 | nitrile; pyridines | |
2-ethoxy-N-[5-(methoxymethyl)-1,3,4-thiadiazol-2-yl]benzamide | [no description available] | medium | 1 | 0 | benzamides | |
vu0099704 | [no description available] | medium | 1 | 0 | ||
3-(4-chlorophenyl)-2,5-dimethyl-1H-pyrazolo[1,5-a]pyrimidin-7-one | [no description available] | medium | 1 | 0 | pyrazoles; ring assembly | |
1-(2-chloro-6-fluorophenyl)-[1,2,4]triazolo[4,3-a]quinoline | [no description available] | medium | 1 | 0 | triazoles | |
2-methyl-N-(1-methyl-2,3-dihydropyrrolo[2,3-b]quinolin-4-yl)propanamide | [no description available] | medium | 1 | 0 | pyrroloquinoline | |
2-methyl-5-[(2-methyl-4-quinolinyl)thio]-1,3,4-thiadiazole | [no description available] | medium | 1 | 0 | aryl sulfide | |
5-methyl-1-(4-nitrophenyl)-2-oxo-2,5-dihydro-1h-pyrido(3,2-b)indole-3-carbonitrile | [no description available] | medium | 1 | 0 | ||
(3-hydroxy-5,6,7,8-tetrahydro-4H-cyclohepta[d]imidazol-2-yl)-phenylmethanone | [no description available] | medium | 1 | 0 | aromatic ketone | |
2-fluoro-N-phenacylbenzamide | [no description available] | medium | 1 | 0 | aromatic ketone | |
4-(methoxymethyl)-6-methyl-2-(2-methylanilino)-3-pyridinecarbonitrile | [no description available] | medium | 1 | 0 | nitrile; pyridines | |
1-azepanyl-[2-methoxy-4-(methylthio)phenyl]methanone | [no description available] | medium | 1 | 0 | carbonyl compound; thiol | |
GS4012 free base | [no description available] | medium | 1 | 0 | aryl sulfide; monomethoxybenzene; pyridines | VEGF activator |
N-[1-(4-methylphenyl)-5-benzimidazolyl]acetamide | [no description available] | medium | 1 | 0 | benzimidazoles | |
2-(4-methylanilino)-1-(4-nitrophenyl)ethanone | [no description available] | medium | 1 | 0 | aromatic ketone | |
N-(2,6-dimethylphenyl)-N(2)-(3,5-dimethylphenyl)glycinamide | [no description available] | medium | 1 | 0 | amino acid amide; glycine derivative | |
2-[4-[(3-fluorophenyl)methyl]-1-piperazinyl]pyrimidine | [no description available] | medium | 1 | 0 | N-arylpiperazine | |
1-[(3,4-dimethoxyphenyl)methyl]-4-(2,3-dimethylphenyl)piperazine | [no description available] | medium | 1 | 0 | piperazines | |
4-Piperidinobenzoic acid | [no description available] | medium | 1 | 0 | piperidines | |
1-(2-methoxyphenyl)-4-(3-thiophenylmethyl)piperazine | [no description available] | medium | 1 | 0 | piperazines | |
N-(1-methyl-2,3-dihydropyrrolo[2,3-b]quinolin-4-yl)-2-(1-pyrrolidinyl)acetamide | [no description available] | medium | 1 | 0 | pyrroloquinoline | |
4-[(1H-benzimidazol-2-ylthio)methyl]-2-thiazolamine | [no description available] | medium | 1 | 0 | benzimidazoles | |
4-[(4-phenyl-2-thiazolyl)amino]benzenesulfonamide | [no description available] | medium | 1 | 0 | sulfonamide | |
N-[7-(1-oxopropyl)-2,3-dihydro-1,4-benzodioxin-6-yl]benzamide | [no description available] | medium | 1 | 0 | benzodioxine | |
N-[3-chloro-4-(1-pyrrolidinyl)phenyl]-2-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; furans | |
n-(pyridin-2-yl)-4-(pyridin-2-yl)thiazol-2-amine | [no description available] | medium | 1 | 0 | ||
8-(3,5-dimethyl-1-pyrazolyl)quinoline | [no description available] | medium | 1 | 0 | quinolines | |
2'-nitroflavone | [no description available] | medium | 1 | 0 | ||
N-(4-methoxyphenyl)-3,4-dihydroquinolin-2-amine | [no description available] | medium | 1 | 0 | aminoquinoline | |
1-(3-nitrophenyl)-3-phenyl-2-propyn-1-one | [no description available] | medium | 1 | 0 | aromatic compound | |
vrt 532 | [no description available] | medium | 1 | 0 | ||
4-[[4-(2,5-dimethylphenyl)-1-piperazinyl]methyl]-2-methoxyphenol | [no description available] | medium | 1 | 0 | piperazines | |
1-piperonylpiperidine | [no description available] | medium | 1 | 0 | ||
2-[(3-fluorophenyl)methyl-(phenylmethyl)amino]ethanol | [no description available] | medium | 1 | 0 | aromatic amine | |
2-methoxy-4-[[2-(methylthio)anilino]methyl]phenol | [no description available] | medium | 1 | 0 | aromatic amine | |
6-ethyl-5-methyl-2-thiophen-2-yl-1H-pyrazolo[1,5-a]pyrimidin-7-one | [no description available] | medium | 1 | 0 | pyrazolopyrimidine | |
N-[4-(2-methyl-4-thiazolyl)phenyl]benzamide | [no description available] | medium | 1 | 0 | benzamides | |
N-(6-phenyl-5-imidazo[2,1-b]thiazolyl)benzamide | [no description available] | medium | 1 | 0 | imidazoles | |
2-(phenylmethylthio)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazole | [no description available] | medium | 1 | 0 | aryl sulfide | |
5-methyl-N-(4,5,6-trimethyl-2-pyrimidinyl)-1,3-benzoxazol-2-amine | [no description available] | medium | 1 | 0 | benzoxazole | |
1-(4-methoxyphenyl)-3-(6-methyl-2-pyridinyl)urea | [no description available] | medium | 1 | 0 | ureas | |
2-{[hydroxy(2-methoxyphenyl)methylidene]amino}acetic acid | [no description available] | medium | 1 | 0 | N-acylglycine | |
(4-methoxyphenyl)-(3-methyl-2-propyl-4-imidazolyl)methanone | [no description available] | medium | 1 | 0 | aromatic ketone | |
N-(3-acetamidophenyl)-2-chlorobenzamide | [no description available] | medium | 1 | 0 | benzamides | |
N4,N4-dimethyl-N1-(4-nitro-1,1-dioxo-2,5-dihydrothiophen-3-yl)benzene-1,4-diamine | [no description available] | medium | 1 | 0 | dialkylarylamine; tertiary amino compound | |
2-bromo-N-(3-methoxyphenyl)benzamide | [no description available] | medium | 1 | 0 | benzamides | |
2-methoxy-4-[(4-methyl-1,4-diazepan-1-yl)methyl]-6-nitrophenol | [no description available] | medium | 1 | 0 | aromatic ether; C-nitro compound | |
3-[[(2,5-dimethyl-3-furanyl)-oxomethyl]amino]benzoic acid | [no description available] | medium | 1 | 0 | aromatic amide; furans | |
1-(4-ethoxyphenyl)-3-(6-quinoxalinyl)urea | [no description available] | medium | 1 | 0 | quinoxaline derivative | |
2-(dimethylsulfamoylamino)-9H-fluorene | [no description available] | medium | 1 | 0 | fluorenes | |
4-chloro-1-ethyl-3-nitro-2-quinolinone | [no description available] | medium | 1 | 0 | nitro compound; quinolines | |
4-chloro-3-nitro-1-(phenylmethyl)-2-quinolinone | [no description available] | medium | 1 | 0 | quinolines | |
2,5-dimethyl-1-(phenylmethyl)pyrrole-3,4-dicarboxaldehyde | [no description available] | medium | 1 | 0 | arenecarbaldehyde | |
2-(2-chloro-6-fluorophenyl)-1-(2,4-dihydroxyphenyl)ethanone | [no description available] | medium | 1 | 0 | stilbenoid | |
4-methyl-N-(3-nitrophenyl)-5-phenyl-3-thiophenecarboxamide | [no description available] | medium | 1 | 0 | aromatic amide | |
N-(5-amino-1-phenyl-1,2,4-triazol-3-yl)-2,2,2-trichloroacetamide | [no description available] | medium | 1 | 0 | triazoles | |
N-(2-fluoro-5-methylphenyl)-3-phenylpropanamide | [no description available] | medium | 1 | 0 | anilide | |
N-[(4-fluorophenyl)methyl]-2-thiophen-2-ylacetamide | [no description available] | medium | 1 | 0 | organofluorine compound | |
4-tert-butyl-N-(1,4-dioxo-2,3-dihydrophthalazin-5-yl)benzamide | [no description available] | medium | 1 | 0 | phthalazines | |
N-[2-(2-methylpropyl)-1,3-dioxo-5-isoindolyl]-2-furancarboxamide | [no description available] | medium | 1 | 0 | phthalimides | |
6-(1,4,5,7-tetramethyl-6-pyrrolo[3,4-d]pyridazinyl)quinoline | [no description available] | medium | 1 | 0 | quinolines | |
2-(3,4-dimethoxyphenyl)-1-(2,4,6-trihydroxyphenyl)ethanone | [no description available] | medium | 1 | 0 | stilbenoid | |
5-(3-chloro-4-methylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole | [no description available] | medium | 1 | 0 | oxadiazole; ring assembly | |
5-(phenylmethyl)-3-(2-pyridinyl)-1,2,4-oxadiazole | [no description available] | medium | 1 | 0 | pyridines | |
2-methyl-5-(1-pyrrolidinyl)isoindole-1,3-dione | [no description available] | medium | 1 | 0 | phthalimides | |
(2'-(4-aminophenyl)-(2,5'-bi-1h-benzimidazol)-5-amine) | [no description available] | medium | 1 | 0 | benzimidazoles | |
N-(4-bromo-2-fluorophenyl)-2-methyl-3-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; furans | |
6,7,8,9-tetrahydro-5H-carbazole-3-carbohydrazide | [no description available] | medium | 1 | 0 | carbazoles | |
N-(3-carbamoyl-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-2-pyrazinecarboxamide | [no description available] | medium | 1 | 0 | primary carboxamide; pyrazines; secondary carboxamide | |
N-(1,3-benzodioxol-5-yl)-5-methyl-2-furancarboxamide | [no description available] | medium | 1 | 0 | benzodioxoles | |
1-cyclohexyl-3-(2,3-dihydro-1,4-benzodioxin-6-yl)urea | [no description available] | medium | 1 | 0 | benzodioxine | |
8-[(2-methyl-5-nitro-1,2,4-triazol-3-yl)thio]quinoline | [no description available] | medium | 1 | 0 | aryl sulfide | |
1-[2-(2-chlorophenoxy)ethyl]benzimidazole | [no description available] | medium | 1 | 0 | benzimidazoles | |
4,5-dimethyl-2-[4-(3-nitrophenyl)-2-thiazolyl]-1H-pyrazol-3-one | [no description available] | medium | 1 | 0 | C-nitro compound | |
2-(4-fluoro-N-methylsulfonylanilino)-N-(3-methylphenyl)acetamide | [no description available] | medium | 1 | 0 | sulfonamide | |
1-(4-fluorophenyl)-2-(2-pyridinylthio)ethanone | [no description available] | medium | 1 | 0 | aromatic ketone | |
3-methyl-6-(1-pyrrolidinyl)-[1,2,4]triazolo[4,3-b]pyridazine | [no description available] | medium | 1 | 0 | triazolopyridazine | |
N-(3-acetylphenyl)-2-thiophen-2-ylacetamide | [no description available] | medium | 1 | 0 | aromatic ketone | |
oncrasin-1 | [no description available] | medium | 1 | 0 | arenecarbaldehyde; indoles; monochlorobenzenes | antineoplastic agent; apoptosis inducer |
N-[2-(4-fluorophenyl)ethyl]-4-nitrobenzamide | [no description available] | medium | 1 | 0 | C-nitro compound | |
5-(1-methyl-2-benzimidazolyl)-2-thiophenecarboxaldehyde | [no description available] | medium | 1 | 0 | benzimidazoles | |
N-(4-anilinophenyl)-2-methylpropanamide | [no description available] | medium | 1 | 0 | anilide | |
N-(2-fluorophenyl)-3-phenylpropanamide | [no description available] | medium | 1 | 0 | anilide | |
1-[(Phenylthio)acetyl]piperidine | [no description available] | medium | 1 | 0 | N-acylpiperidine | |
N-(3-hydroxyphenyl)-5-methyl-3-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; furans | |
3-(4-methoxyphenyl)-5-(4-methylphenyl)-1,2,4-oxadiazole | [no description available] | medium | 1 | 0 | oxadiazole; ring assembly | |
4-[(4-carboxy-2,6-dimethoxyphenoxy)methyl]-5-methyl-2-furancarboxylic acid | [no description available] | medium | 1 | 0 | trihydroxybenzoic acid | |
4-(4-morpholinylmethyl)-3-quinolinol | [no description available] | medium | 1 | 0 | quinolines | |
2-bromo-N-[3-(1-oxopropylamino)phenyl]benzamide | [no description available] | medium | 1 | 0 | benzamides | |
3-acetyl-2-methylbenzo[f]benzofuran-4,9-dione | [no description available] | medium | 1 | 0 | naphthofuran | |
5-(4-chlorophenyl)-N-(5-ethyl-1,3,4-thiadiazol-2-yl)-2-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; heteroarene | |
1-azepanyl-[4-[(phenylthio)methyl]phenyl]methanone | [no description available] | medium | 1 | 0 | benzamides | |
1-(5-ethyl-2,4-dihydroxyphenyl)-2-(2-fluorophenoxy)ethanone | [no description available] | medium | 1 | 0 | aromatic ketone | |
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-(2-nitrophenyl)acetamide | [no description available] | medium | 1 | 0 | acetamides | |
3,4,5-triethoxy-N-(1H-1,2,4-triazol-5-yl)benzamide | [no description available] | medium | 1 | 0 | benzamides | |
1-propylsulfonyl-4-(2-pyridinyl)piperazine | [no description available] | medium | 1 | 0 | piperazines; pyridines | |
2-(2-phenylethylthio)-3-pyridinecarboxylic acid | [no description available] | medium | 1 | 0 | aromatic carboxylic acid; pyridines | |
2-(2,3-dimethylphenoxy)-N-pyridin-4-ylacetamide | [no description available] | medium | 1 | 0 | aromatic ether | |
2-[[anilino(oxo)methyl]amino]-N-(phenylmethyl)benzamide | [no description available] | medium | 1 | 0 | benzamides | |
N-(5-acetyl-4-methyl-2-thiazolyl)-5-bromo-2-furancarboxamide | [no description available] | medium | 1 | 0 | thiazoles | |
1-cyclohexyl-3-(3-ethylphenyl)urea | [no description available] | medium | 1 | 0 | ureas | |
n-phenylpiracetam | [no description available] | medium | 1 | 0 | ||
2-[(1-methyl-5-tetrazolyl)thio]-N-(2-phenylphenyl)acetamide | [no description available] | medium | 1 | 0 | biphenyls | |
N-[3-chloro-4-(1-pyrrolidinyl)phenyl]-2-nitrobenzamide | [no description available] | medium | 1 | 0 | benzamides | |
4-(3,4-dihydro-1H-isoquinolin-2-ylmethyl)-N-(2,6-dimethylphenyl)benzamide | [no description available] | medium | 1 | 0 | isoquinolines | |
5-(4-bromophenyl)-N-(2-methoxyphenyl)-2-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; furans | |
3-[[(3,5-dichloro-4-ethoxyphenyl)-oxomethyl]amino]benzoic acid | [no description available] | medium | 1 | 0 | benzamides | |
1,4-bis(thiophen-2-ylsulfonyl)piperazine | [no description available] | medium | 1 | 0 | N-sulfonylpiperazine; thiophenes | |
2-bromo-N-[3-(1-oxobutylamino)phenyl]benzamide | [no description available] | medium | 1 | 0 | benzamides | |
1-(2-fluorophenyl)-4-[(6-nitro-1,3-benzodioxol-5-yl)methyl]piperazine | [no description available] | medium | 1 | 0 | piperazines | |
n-(1-benzyl-4-piperidinyl)-2,4-dichlorobenzamide | [no description available] | medium | 1 | 0 | ||
2-[[2-(5-methyl-2-thiophenyl)-2-oxoethyl]thio]-3-phenyl-4-quinazolinone | [no description available] | medium | 1 | 0 | quinazolines | |
1-(2,1,3-benzothiadiazol-5-yl)-3-[4-(4-morpholinyl)phenyl]urea | [no description available] | medium | 1 | 0 | morpholines | |
ethyl 4-{N-[(4-chlorophenyl)sulfonyl]-N-methylglycyl}piperazine-1-carboxylate | [no description available] | medium | 1 | 0 | carbamate ester; sulfonamide | |
LSM-4563 | [no description available] | medium | 1 | 0 | aromatic ketone | |
1-(4-chloro-3-methoxyphenyl)sulfonyl-4-phenylpiperazine | [no description available] | medium | 1 | 0 | piperazines | |
N-[4-[(3,4-dimethoxyphenyl)sulfamoyl]phenyl]acetamide | [no description available] | medium | 1 | 0 | sulfonamide | |
4-chloro-3-(1-piperidinylsulfonyl)-N-(2-thiazolyl)benzamide | [no description available] | medium | 1 | 0 | sulfonamide | |
1-(2,5-dimethoxyphenyl)sulfonyl-4-(phenylmethyl)piperazine | [no description available] | medium | 1 | 0 | sulfonamide | |
2-(4-methoxyphenyl)-N-[4-[(5-methyl-3-isoxazolyl)sulfamoyl]phenyl]acetamide | [no description available] | medium | 1 | 0 | sulfonamide | |
4-[4-(benzenesulfonyl)-1-piperazinyl]-2-methylquinoline | [no description available] | medium | 1 | 0 | piperazines; pyridines | |
1-(6-methoxy-2,2,4-trimethyl-1-quinolinyl)-2-[[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]thio]ethanone | [no description available] | medium | 1 | 0 | quinolines | |
N2-phenyl-6-[[(1-phenyl-5-tetrazolyl)thio]methyl]-1,3,5-triazine-2,4-diamine | [no description available] | medium | 1 | 0 | tetrazoles | |
2-[(4,6-dimethyl-2-pyrimidinyl)thio]-N-(4,5-diphenyl-2-oxazolyl)acetamide | [no description available] | medium | 1 | 0 | 1,3-oxazoles | |
2-(4-bromophenyl)-1-[4-(2-pyridinyl)-1-piperazinyl]ethanone | [no description available] | medium | 1 | 0 | piperazines; pyridines | |
2-amino[1,3]thiazolo[4,5-d]pyrimidine-5,7-diol | [no description available] | medium | 1 | 0 | thiazolopyrimidine | |
3-[[(2-cyclohexyl-1,3-dioxo-5-isoindolyl)-oxomethyl]amino]benzoic acid | [no description available] | medium | 1 | 0 | aromatic amide | |
3-[[[3-(1-azepanylsulfonyl)-4-chlorophenyl]-oxomethyl]amino]benzoic acid | [no description available] | medium | 1 | 0 | benzamides | |
2-(4-bromophenyl)-N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)acetamide | [no description available] | medium | 1 | 0 | acetamides | |
5-(1,3-benzodioxol-5-ylsulfamoyl)-2-methoxybenzoic acid | [no description available] | medium | 1 | 0 | methoxybenzoic acid | |
N-cycloheptyl-1-(4-methylphenyl)sulfonyl-4-piperidinecarboxamide | [no description available] | medium | 1 | 0 | sulfonamide | |
3-(2-chlorophenyl)-5-methyl-N-[4-[2-(4-morpholinyl)-2-oxoethoxy]phenyl]-4-isoxazolecarboxamide | [no description available] | medium | 1 | 0 | aromatic amide | |
N-[3-[[(4-nitrophenyl)-oxomethyl]amino]phenyl]-2-furancarboxamide | [no description available] | medium | 1 | 0 | benzamides | |
3-methyl-1,5-dithiophen-2-ylpentane-1,5-dione | [no description available] | medium | 1 | 0 | aromatic ketone | |
N-(2-methyl-1,3-benzothiazol-6-yl)-4-(4-morpholinylsulfonyl)benzamide | [no description available] | medium | 1 | 0 | sulfonamide | |
4-(dimethylsulfamoyl)-N-(4-thiophen-2-yl-2-thiazolyl)benzamide | [no description available] | medium | 1 | 0 | sulfonamide | |
3-chloro-N-[4-[(1-oxo-2-phenylethyl)amino]phenyl]benzamide | [no description available] | medium | 1 | 0 | benzamides | |
N-(3,4-dimethoxyphenyl)-4-[(4-phenyl-1-piperazinyl)methyl]benzamide | [no description available] | medium | 1 | 0 | benzamides | |
stk295900 | [no description available] | medium | 1 | 0 | ||
1-(3-chlorophenyl)-4-[(3,4,5-trimethoxyphenyl)methyl]piperazine | [no description available] | medium | 1 | 0 | piperazines | |
2-[4-[[4-(4-methoxyphenyl)-1-phthalazinyl]amino]phenyl]acetamide | [no description available] | medium | 1 | 0 | pyridazines; ring assembly | |
1-(2-fluorophenyl)-3-[5-(2-fluorophenyl)-1,3,4-thiadiazol-2-yl]urea | [no description available] | medium | 1 | 0 | ureas | |
N-[5-[(4-methoxyphenyl)methyl]-1,3,4-thiadiazol-2-yl]-2-furancarboxamide | [no description available] | medium | 1 | 0 | methoxybenzenes | |
N-(1,3-benzodioxol-5-yl)-4-methyl-1-phthalazinamine | [no description available] | medium | 1 | 0 | phthalazines | |
SMER 28 | [no description available] | medium | 1 | 0 | organobromine compound; quinazolines; secondary amino compound | autophagy inducer |
N-[4-(4-morpholinyl)phenyl]carbamic acid butyl ester | [no description available] | medium | 1 | 0 | morpholines | |
4-(4-chlorophenoxy)-1-(4-morpholinyl)-1-butanone | [no description available] | medium | 1 | 0 | aromatic ether | |
4-(4-chlorophenoxy)-1-(1-piperidinyl)-1-butanone | [no description available] | medium | 1 | 0 | N-acylpiperidine | |
N-(3-phenylpropyl)methanesulfonamide | [no description available] | medium | 1 | 0 | benzenes | |
4-acetamido-N-(2-methoxyethyl)benzamide | [no description available] | medium | 1 | 0 | amidobenzoic acid | |
2-methyl-N-(2,3,4,5,6-pentafluorophenyl)-3-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; furans | |
3,4-dihydro-2H-quinolin-1-yl-(4-propoxyphenyl)methanone | [no description available] | medium | 1 | 0 | quinolines | |
5-bromo-N-(2-phenylphenyl)-2-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; furans | |
2-[2-(4-chlorophenoxy)ethylthio]pyrimidine | [no description available] | medium | 1 | 0 | aromatic ether | |
3-(3-bromoanilino)-1-(5-methyl-2-furanyl)-1-propanone | [no description available] | medium | 1 | 0 | aralkylamine | |
4-[2-(4-bromo-2-chlorophenoxy)-1-oxoethyl]-1-piperazinecarboxylic acid ethyl ester | [no description available] | medium | 1 | 0 | piperazinecarboxylic acid | |
2-[2-[[3-(1,3-benzoxazol-2-yl)anilino]-oxomethyl]phenyl]benzoic acid | [no description available] | medium | 1 | 0 | benzamides | |
1-[2-(2-chlorophenoxy)ethoxy]-2-methoxy-4-methylbenzene | [no description available] | medium | 1 | 0 | methoxybenzenes | |
N-[4-[(4-sulfamoylphenyl)sulfamoyl]phenyl]cyclopropanecarboxamide | [no description available] | medium | 1 | 0 | sulfonamide | |
4-[2-[2-(4-bromo-2-chlorophenoxy)ethoxy]ethyl]morpholine | [no description available] | medium | 1 | 0 | aromatic ether | |
N-[2-(2-phenylphenoxy)ethyl]-2-furancarboxamide | [no description available] | medium | 1 | 0 | biphenyls | |
5,6,7,8-tetrafluoro-2-(2,3,4,5,6-pentafluorophenyl)-4h-1-benzopyran-4-one | [no description available] | medium | 1 | 0 | ||
2-[bis(5-methyl-2-furanyl)methyl]-6-nitrophenol | [no description available] | medium | 1 | 0 | nitrophenol | |
2-(4-nitrophenyl)-N-(2-oxolanylmethyl)-4-quinazolinamine | [no description available] | medium | 1 | 0 | quinazolines | |
2-(4-hydroxy-1,3-thiazol-2-yl)-1-phenylethan-1-one | [no description available] | medium | 1 | 0 | aromatic ketone | |
Methyl(2-furoylamino)acetic acid | [no description available] | medium | 1 | 0 | N-acyl-amino acid | |
5-nitro-8-(1-pyrrolidinyl)quinoline | [no description available] | medium | 1 | 0 | nitro compound; quinolines | |
2-(3-oxo-2,4-dihydro-1H-quinoxalin-2-yl)-N-phenylacetamide | [no description available] | medium | 1 | 0 | amino acid amide | |
2-[(4-methylphenyl)sulfonylamino]pentanoic acid | [no description available] | medium | 1 | 0 | sulfonamide | |
4,6-dimorpholino-n-(4-nitrophenyl)-1,3,5-triazin-2-amine | [no description available] | medium | 1 | 0 | ||
1-[(3-chlorophenyl)methyl]-N,N-diethyl-3-piperidinecarboxamide | [no description available] | medium | 1 | 0 | piperidines | |
1-(2,6-dimethyl-1-piperidinyl)-2-phenylethanone | [no description available] | medium | 1 | 0 | acetamides | |
2-amino-7-methyl-5-oxo-4-(2,3,4-trimethoxyphenyl)-4,6,7,8-tetrahydro-1-benzopyran-3-carbonitrile | [no description available] | medium | 1 | 0 | methoxybenzenes | |
3-[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]-1-phenylpyrrolidine-2,5-dione | [no description available] | medium | 1 | 0 | pyrrolidines | |
1-(4-bromophenyl)-3-(diethylamino)pyrrolidine-2,5-dione | [no description available] | medium | 1 | 0 | pyrrolidines | |
4-(5,6-diphenyl-1,2,4-triazin-3-yl)morpholine | [no description available] | medium | 1 | 0 | dialkylarylamine; tertiary amino compound | |
(3,5-Dimethyl-1-adamantyl)amine nitrate | [no description available] | medium | 1 | 0 | nitrates | |
1-(4-tert-butylphenoxy)-3-(1H-1,2,4-triazol-5-ylthio)-2-propanol | [no description available] | medium | 1 | 0 | alkylbenzene | |
N-[2-(1-methyl-2-pyrrolidinyl)ethyl]-2-adamantanamine | [no description available] | medium | 1 | 0 | N-alkylpyrrolidine | |
4-phenyl-N-(pyridin-4-ylmethyl)-2-butanamine | [no description available] | medium | 1 | 0 | aralkylamine | |
N-(5-nitro-2-pyridinyl)cyclopropanecarboxamide | [no description available] | medium | 1 | 0 | aromatic amide | |
3-[(4-bromophenyl)methyl]-4-(4-methoxyanilino)-4-oxobutanoic acid | [no description available] | medium | 1 | 0 | anilide | |
3-ethyl-N-(2H-tetrazol-5-yl)-1-adamantanecarboxamide | [no description available] | medium | 1 | 0 | aromatic amide | |
N-(4-propan-2-ylphenyl)-3-bicyclo[2.2.1]heptanecarboxamide | [no description available] | medium | 1 | 0 | monoterpenoid | |
4-chloro-N-[2-(4-nitroanilino)ethyl]benzamide | [no description available] | medium | 1 | 0 | carbonyl compound; organohalogen compound | |
2-[(2,3-dihydro-1,4-benzodioxin-6-ylamino)-oxomethyl]-1-cyclohexanecarboxylic acid | [no description available] | medium | 1 | 0 | benzodioxine | |
2,4-dichloro-6-[1-(4-morpholinyl)-3-phenylprop-2-ynyl]phenol | [no description available] | medium | 1 | 0 | aromatic compound | |
2-[[1-(4-ethoxyphenyl)-2,5-dioxo-3-pyrrolidinyl]amino]acetonitrile | [no description available] | medium | 1 | 0 | pyrrolidines | |
1-ethoxy-3-(2-methoxy-4-prop-2-enylphenoxy)-2-propanol | [no description available] | medium | 1 | 0 | methoxybenzenes | |
6-amino-4-(3-chlorophenyl)-3-methyl-1-(phenylmethyl)-4H-pyrano[2,3-c]pyrazole-5-carbonitrile | [no description available] | medium | 1 | 0 | organochlorine compound; pyranopyrazole | |
1-(2-chlorophenoxy)-3-(2-methyl-1-benzimidazolyl)-2-propanol | [no description available] | medium | 1 | 0 | benzimidazoles | |
N-[2-furanyl-(8-hydroxy-7-quinolinyl)methyl]-2-methylpropanamide | [no description available] | medium | 1 | 0 | hydroxyquinoline | |
N-(2-hydroxy-5-methylphenyl)-2-furancarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; furans | |
4-amino-7,8,9,10-tetrahydro-6H-pyrimido[3,4]pyrrolo[3,5-a]azepine-11-carbonitrile | [no description available] | medium | 1 | 0 | organic heterobicyclic compound; organonitrogen heterocyclic compound | |
1-(3,5-dimethylphenyl)-3-(1H-1,2,4-triazol-5-ylthio)pyrrolidine-2,5-dione | [no description available] | medium | 1 | 0 | pyrrolidines | |
6-[(3,4-difluoroanilino)-oxomethyl]-1-cyclohex-3-enecarboxylic acid | [no description available] | medium | 1 | 0 | anilide | |
4-[(3-cyano-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophen-2-yl)amino]-4-oxobutanoic acid | [no description available] | medium | 1 | 0 | organosulfur heterocyclic compound | |
[3-methyl-4-[oxo(thiophen-2-yl)methyl]-1-piperazinyl]-thiophen-2-ylmethanone | [no description available] | medium | 1 | 0 | aromatic amide; thiophenes | |
[4-(2-methoxyphenyl)-1-piperazinyl]-[4-[(phenylthio)methyl]phenyl]methanone | [no description available] | medium | 1 | 0 | piperazines | |
N-(3,3,5-trimethylcyclohexyl)-1H-1,2,4-triazole-5-carboxamide | [no description available] | medium | 1 | 0 | aromatic amide; heteroarene | |
4-[2-nitro-5-[4-(phenylmethyl)sulfonyl-1-piperazinyl]phenyl]morpholine | [no description available] | medium | 1 | 0 | piperazines | |
5-(4-ethylsulfonyl-1-piperazinyl)-2-nitro-N-(3-pyridinylmethyl)aniline | [no description available] | medium | 1 | 0 | piperazines | |
2-[[5-[(1,3-benzothiazol-2-ylthio)methyl]-4-methyl-1,2,4-triazol-3-yl]thio]-N-[2-(4-morpholinyl)ethyl]acetamide | [no description available] | medium | 1 | 0 | benzothiazoles | |
N-ethyl-N-[2-[(5-nitro-8-quinolinyl)amino]ethyl]benzenesulfonamide | [no description available] | medium | 1 | 0 | nitro compound; quinolines | |
1-(4-methoxyphenyl)-N-(4-methyl-2-pyridinyl)-5-oxo-3-pyrrolidinecarboxamide | [no description available] | medium | 1 | 0 | pyrrolidines | |
3,4,5-trimethoxy-N-[4-[(2-methyl-1-piperidinyl)sulfonyl]phenyl]benzamide | [no description available] | medium | 1 | 0 | benzamides | |
3-(n,n-dimethylsulfonamido)-4-methyl-nitrobenzene | [no description available] | medium | 1 | 0 | C-nitro compound; sulfonamide; toluenes | bone density conservation agent; EC 3.1.4.53 (3',5'-cyclic-AMP phosphodiesterase) inhibitor; geroprotector |
6,3',4'-Trimethoxyflavanone | [no description available] | medium | 1 | 0 | ether; flavonoids | |
1-[4-(3-ethoxyphenoxy)butyl]imidazole | [no description available] | medium | 1 | 0 | aromatic ether | |
5-[[(1-cyclohexyl-5-tetrazolyl)thio]methyl]-3-phenyl-1,2,4-oxadiazole | [no description available] | medium | 1 | 0 | oxadiazole; ring assembly | |
2-[1-(3,4-dihydro-2H-quinolin-1-yl)-1-oxopropan-2-yl]isoindole-1,3-dione | [no description available] | medium | 1 | 0 | phthalimides | |
[4-(benzenesulfonyl)-1-piperazinyl]-(1-piperidinyl)methanone | [no description available] | medium | 1 | 0 | sulfonamide | |
3-(2,5-dioxo-1-pyrrolidinyl)-N-(2-methyl-1,3-dioxo-5-isoindolyl)benzamide | [no description available] | medium | 1 | 0 | amidobenzoic acid | |
6-[[[5-(ethylthio)-1,3,4-thiadiazol-2-yl]amino]-oxomethyl]-1-cyclohex-3-enecarboxylic acid | [no description available] | medium | 1 | 0 | aromatic amide | |
2,5-dimethoxy-n-(quinolin-3-yl)benzenesulfonamide | [no description available] | medium | 1 | 0 | quinolines | |
LSM-25805 | [no description available] | medium | 1 | 0 | isoindoles | |
4-ethoxy-N-(3-quinolinyl)benzenesulfonamide | [no description available] | medium | 1 | 0 | quinolines | |
3-chloro-N-[3-(1-imidazolyl)propyl]-6-nitro-1-benzothiophene-2-carboxamide | [no description available] | medium | 1 | 0 | 1-benzothiophenes | |
nsc 727447 | [no description available] | medium | 1 | 0 | ||
2-methoxy-N-[(4-methylphenyl)methyl]-2-phenylacetamide | [no description available] | medium | 1 | 0 | acetamides | |
2-(4-chlorophenoxy)-N-(5-nitro-2-thiazolyl)acetamide | [no description available] | medium | 1 | 0 | C-nitro compound; thiazoles | |
7-(2-methoxyphenyl)-5-phenyl-1,7-dihydrotetrazolo[1,5-a]pyrimidine | [no description available] | medium | 1 | 0 | methoxybenzenes | |
N-[3-[2,5-dioxo-3-(phenylmethyl)-1-pyrrolidinyl]phenyl]acetamide | [no description available] | medium | 1 | 0 | pyrrolidines | |
3,4-dimethoxy-N-[3-(methylthio)phenyl]benzenesulfonamide | [no description available] | medium | 1 | 0 | sulfonamide | |
3-methyl-4-nitro-N-(1H-1,2,4-triazol-5-yl)benzamide | [no description available] | medium | 1 | 0 | C-nitro compound | |
2-[(4-chlorophenyl)methylthio]-N-(2-hydroxy-5-nitrophenyl)acetamide | [no description available] | medium | 1 | 0 | nitrophenol | |
2-(4-ethoxyphenyl)-N-[3-(1-imidazolyl)propyl]-4-quinolinecarboxamide | [no description available] | medium | 1 | 0 | quinolines | |
N-(4-bromophenyl)-5-methyl-4-nitro-1H-pyrazol-3-amine | [no description available] | medium | 1 | 0 | C-nitro compound | |
3,3-bis(4-hydroxyphenyl)-7-methyl-1,3-dihydro-2h-indol-2-one | [no description available] | medium | 1 | 0 | ||
N-[4-[(cyclohexylamino)-oxomethyl]phenyl]-3-pyridinecarboxamide | [no description available] | medium | 1 | 0 | aromatic amide | |
N,N,4-trimethyl-2-[[(5-methyl-2-furanyl)-oxomethyl]amino]-5-thiazolecarboxamide | [no description available] | medium | 1 | 0 | aromatic amide; thiazoles | |
ex 527 | [no description available] | medium | 1 | 0 | carbazoles; monocarboxylic acid amide; organochlorine compound | |
3-[3-[(5-ethyl-[1,2,4]triazino[5,6-b]indol-3-yl)thio]propyl]-1H-benzimidazol-2-one | [no description available] | medium | 1 | 0 | indoles | |
4-methyl-2,7-diphenyl-8H-pyrido[2,3-d]pyrimidin-5-one | [no description available] | medium | 1 | 0 | phenylpyridine | |
3-methylharman | [no description available] | medium | 1 | 0 | ||
1-methyl-beta-carboline-3-carboxylic acid | [no description available] | medium | 1 | 0 | ||
sildenafil | [no description available] | medium | 1 | 0 | piperazines; pyrazolopyrimidine; sulfonamide | EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor; vasodilator agent |
2-methyl-4(3h)-quinazolinone | [no description available] | medium | 1 | 0 | ||
n(4)-desoxychlordiazepoxide | [no description available] | medium | 1 | 0 | ||
2-amino-3-hydroxyphenazine | [no description available] | medium | 1 | 0 | ||
2-styrylquinazolin-4(3h)-one | [no description available] | medium | 1 | 0 | ||
2-amino-5-iodo-6-phenyl-4-pyrimidinone | [no description available] | medium | 1 | 0 | ||
quininib | [no description available] | medium | 1 | 0 | phenols; styrylquinoline | angiogenesis inhibitor |
bropirimine | [no description available] | medium | 1 | 0 | pyrimidines | |
2-[(6-ethyl-4-methyl-2-quinazolinyl)amino]-1H-quinazolin-4-one | [no description available] | medium | 1 | 0 | quinazolines | |
2-[(6-ethyl-4-methyl-2-quinazolinyl)amino]-6-(methoxymethyl)-1H-pyrimidin-4-one | [no description available] | medium | 1 | 0 | quinazolines | |
2,4-dichlorophenoxyacetic acid | [no description available] | low | 0 | 0 | chlorophenoxyacetic acid; dichlorobenzene | agrochemical; defoliant; EC 1.1.1.25 (shikimate dehydrogenase) inhibitor; environmental contaminant; phenoxy herbicide; synthetic auxin |
am 251 | [no description available] | low | 0 | 0 | amidopiperidine; carbohydrazide; dichlorobenzene; organoiodine compound; pyrazoles | antidepressant; antineoplastic agent; apoptosis inducer; CB1 receptor antagonist |
apraclonidine | [no description available] | low | 0 | 0 | dichlorobenzene; guanidines; imidazolines | alpha-adrenergic agonist; antiglaucoma drug; beta-adrenergic agonist; diagnostic agent; ophthalmology drug |
bithionol | [no description available] | low | 0 | 0 | aryl sulfide; bridged diphenyl antifungal drug; bridged diphenyl fungicide; dichlorobenzene; organochlorine pesticide; polyphenol | antifungal agrochemical; antiplatyhelmintic drug |
clenbuterol | [no description available] | low | 0 | 0 | amino alcohol; dichlorobenzene; ethanolamines; primary arylamine; secondary amino compound; substituted aniline | beta-adrenergic agonist; bronchodilator agent; sympathomimetic agent |
dicamba | [no description available] | low | 0 | 0 | dichlorobenzene; methoxybenzoic acid | agrochemical; environmental contaminant; herbicide; synthetic auxin; xenobiotic |
dichlobanil | [no description available] | low | 0 | 0 | dichlorobenzene; nitrile | agrochemical; cellulose synthesis inhibitor; environmental contaminant; herbicide; xenobiotic |
dichlorphenamide | [no description available] | low | 0 | 0 | dichlorobenzene; sulfonamide | antiglaucoma drug; EC 4.2.1.1 (carbonic anhydrase) inhibitor; ophthalmology drug |
econazole | [no description available] | low | 0 | 0 | dichlorobenzene; ether; imidazoles; monochlorobenzenes | |
ethacrynic acid | [no description available] | low | 0 | 0 | aromatic ether; aromatic ketone; dichlorobenzene; monocarboxylic acid | EC 2.5.1.18 (glutathione transferase) inhibitor; ion transport inhibitor; loop diuretic |
felodipine | [no description available] | low | 0 | 0 | dichlorobenzene; dihydropyridine; ethyl ester; methyl ester | anti-arrhythmia drug; antihypertensive agent; calcium channel blocker; vasodilator agent |
fipronil | [no description available] | low | 0 | 0 | (trifluoromethyl)benzenes; dichlorobenzene; nitrile; primary amino compound; pyrazoles; sulfoxide | |
liquid crystal polymer | [no description available] | low | 0 | 0 | conazole fungicide; dichlorobenzene; organobromine compound; oxolanes; triazole fungicide; triazoles | antifungal agrochemical; EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor |
irsogladine | [no description available] | low | 0 | 0 | dichlorobenzene | |
isoconazole | [no description available] | low | 0 | 0 | dichlorobenzene; ether; imidazoles | |
ketoconazole | [no description available] | low | 0 | 0 | dichlorobenzene; dioxolane; ether; imidazoles; N-acylpiperazine; N-arylpiperazine | |
lamotrigine | [no description available] | low | 0 | 0 | 1,2,4-triazines; dichlorobenzene; primary arylamine | anticonvulsant; antidepressant; antimanic drug; calcium channel blocker; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; environmental contaminant; excitatory amino acid antagonist; geroprotector; non-narcotic analgesic; xenobiotic |
lorglumide | [no description available] | low | 0 | 0 | benzamides; dicarboxylic acid monoamide; dichlorobenzene; glutamic acid derivative | |
miconazole | [no description available] | low | 0 | 0 | dichlorobenzene; ether; imidazoles | |
clorgyline | [no description available] | low | 0 | 0 | aromatic ether; dichlorobenzene; terminal acetylenic compound; tertiary amino compound | antidepressant; EC 1.4.3.4 (monoamine oxidase) inhibitor |
4-dichlorobenzene | [no description available] | low | 0 | 0 | dichlorobenzene | insecticide |
methazole | [no description available] | low | 0 | 0 | dichlorobenzene | |
sulconazole | [no description available] | low | 0 | 0 | dichlorobenzene; imidazoles; monochlorobenzenes; organic sulfide | |
tioconazole | [no description available] | low | 0 | 0 | dichlorobenzene; ether; imidazoles; thiophenes | |
triclosan | [no description available] | low | 0 | 0 | aromatic ether; dichlorobenzene; monochlorobenzenes; phenols | antibacterial agent; antimalarial; drug allergen; EC 1.3.1.9 [enoyl-[acyl-carrier-protein] reductase (NADH)] inhibitor; EC 1.5.1.3 (dihydrofolate reductase) inhibitor; fungicide; persistent organic pollutant; xenobiotic |
2,6-dichlorobenzoic acid | [no description available] | low | 0 | 0 | chlorobenzoic acid; dichlorobenzene | bacterial xenobiotic metabolite |
2,5-dichlorobenzoic acid | [no description available] | low | 0 | 0 | chlorobenzoic acid; dichlorobenzene | |
2,4-dichlorobenzoic acid | [no description available] | low | 0 | 0 | chlorobenzoic acid; dichlorobenzene | bacterial metabolite |
2-dichlorobenzene | [no description available] | low | 0 | 0 | dichlorobenzene | hepatotoxic agent; metabolite |
2,4-dichlorotoluene | [no description available] | low | 0 | 0 | dichlorobenzene | |
dicloran | [no description available] | low | 0 | 0 | aromatic fungicide; dichlorobenzene; nitroaniline | antifungal agrochemical |
triclocarban | [no description available] | low | 0 | 0 | dichlorobenzene; monochlorobenzenes; phenylureas | antimicrobial agent; antiseptic drug; disinfectant; environmental contaminant; xenobiotic |
dichlorprop | [no description available] | low | 0 | 0 | aromatic ether; dichlorobenzene; monocarboxylic acid | |
linuron | [no description available] | low | 0 | 0 | dichlorobenzene; phenylureas | agrochemical; environmental contaminant; herbicide; xenobiotic |
chlorfenvinphos | [no description available] | low | 0 | 0 | dichlorobenzene; organic phosphate; organochlorine acaricide; organochlorine insecticide; organophosphate insecticide | agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor |
1,3-dichlorobenzene | [no description available] | low | 0 | 0 | dichlorobenzene | |
2,6-dichloroindophenol | [no description available] | low | 0 | 0 | dichlorobenzene; quinone imine | |
3,3',4',5-tetrachlorosalicylanilide | [no description available] | low | 0 | 0 | dichlorobenzene; salicylanilides | drug allergen |
dichlorobenzyl alcohol | [no description available] | low | 0 | 0 | benzyl alcohols; dichlorobenzene | antiseptic drug |
2,6-dichlorobenzamide | [no description available] | low | 0 | 0 | benzamides; dichlorobenzene | herbicide; marine xenobiotic metabolite |
3,4-dichlorophenylurea | [no description available] | low | 0 | 0 | dichlorobenzene; phenylureas | marine xenobiotic metabolite |
chloroneb | [no description available] | low | 0 | 0 | aromatic fungicide; dichlorobenzene; dimethoxybenzene | antifungal agrochemical |
dicloxacillin | [no description available] | low | 0 | 0 | dichlorobenzene; penicillin | antibacterial drug |
clonidine hydrochloride | [no description available] | low | 0 | 0 | dichlorobenzene | |
lofexidine | [no description available] | low | 0 | 0 | aromatic ether; carboxamidine; dichlorobenzene; imidazoles | alpha-adrenergic agonist; antihypertensive agent |
leptophos | [no description available] | low | 0 | 0 | bromobenzenes; dichlorobenzene; organic phosphonate; phosphonic ester | |
pronamide | [no description available] | low | 0 | 0 | benzamides; dichlorobenzene; terminal acetylenic compound | agrochemical; herbicide |
pcb 118 | [no description available] | low | 0 | 0 | dichlorobenzene; pentachlorobiphenyl; trichlorobenzene | |
3,4,3',4'-tetrachlorobiphenyl | [no description available] | low | 0 | 0 | dichlorobenzene; tetrachlorobiphenyl | |
2,3,3',4,4'-pentachlorobiphenyl | [no description available] | low | 0 | 0 | dichlorobenzene; pentachlorobiphenyl; trichlorobenzene | |
prothiophos | [no description available] | low | 0 | 0 | dichlorobenzene; organic thiophosphate; organosulfur compound | agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; insecticide |
2,5-dichlorobiphenyl | [no description available] | low | 0 | 0 | dichlorobenzene; dichlorobiphenyl | |
enilconazole | [no description available] | low | 0 | 0 | dichlorobenzene; ether; imidazoles | |
2,5,2',5'-tetrachlorobiphenyl | [no description available] | low | 0 | 0 | dichlorobenzene; tetrachlorobiphenyl | |
2,3,3',4,4',5-hexachlorobiphenyl | [no description available] | low | 0 | 0 | dichlorobenzene; hexachlorobiphenyl; tetrachlorobenzene | |
ticrynafen | [no description available] | low | 0 | 0 | aromatic ether; aromatic ketone; dichlorobenzene; monocarboxylic acid; thiophenes | antihypertensive agent; hepatotoxic agent; loop diuretic |
2-(4-(2,4-dichlorophenoxy)phenoxy)propionic acid | [no description available] | low | 0 | 0 | aromatic ether; dichlorobenzene; diether; monocarboxylic acid | |
lonidamine | [no description available] | low | 0 | 0 | dichlorobenzene; indazoles; monocarboxylic acid | antineoplastic agent; antispermatogenic agent; EC 2.7.1.1 (hexokinase) inhibitor; geroprotector |
vinclozolin | [no description available] | low | 0 | 0 | dicarboximide; dichlorobenzene; olefinic compound; oxazolidinone | |
dichlorfop-methyl | [no description available] | low | 0 | 0 | aromatic ether; dichlorobenzene; diether; methyl ester | |
muzolimine | [no description available] | low | 0 | 0 | dichlorobenzene | |
azaconazole | [no description available] | low | 0 | 0 | conazole fungicide; cyclic ketal; dichlorobenzene; dioxolane; triazole fungicide; triazoles | antifungal agrochemical; EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor |
propiconazole | [no description available] | low | 0 | 0 | conazole fungicide; cyclic ketal; dichlorobenzene; triazole fungicide; triazoles | antifungal agrochemical; EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor; environmental contaminant; xenobiotic |
butoconazole | [no description available] | low | 0 | 0 | aryl sulfide; conazole antifungal drug; dichlorobenzene; imidazole antifungal drug; imidazoles; monochlorobenzenes | |
dichlozolinate | [no description available] | low | 0 | 0 | dicarboximide; dichlorobenzene; ethyl ester; oxazolidinone | |
fenticonazole | [no description available] | low | 0 | 0 | aryl sulfide; dichlorobenzene; ether; imidazoles | |
itraconazole | [no description available] | low | 0 | 0 | aromatic ether; conazole antifungal drug; cyclic ketal; dichlorobenzene; dioxolane; N-arylpiperazine; triazole antifungal drug; triazoles | EC 3.6.3.44 (xenobiotic-transporting ATPase) inhibitor; Hedgehog signaling pathway inhibitor; P450 inhibitor |
aripiprazole | [no description available] | low | 0 | 0 | aromatic ether; delta-lactam; dichlorobenzene; N-alkylpiperazine; N-arylpiperazine; quinolone | drug metabolite; H1-receptor antagonist; second generation antipsychotic; serotonergic agonist |
tobanum | [no description available] | low | 0 | 0 | dichlorobenzene | |
sertaconazole | [no description available] | low | 0 | 0 | 1-benzothiophenes; dichlorobenzene; ether; imidazoles | |
hexaconazole | [no description available] | low | 0 | 0 | dichlorobenzene; tertiary alcohol; triazoles | chelator |
sertraline | [no description available] | low | 0 | 0 | dichlorobenzene; secondary amino compound; tetralins | antidepressant; serotonin uptake inhibitor |
aceclofenac | [no description available] | low | 0 | 0 | amino acid; carboxylic ester; dichlorobenzene; monocarboxylic acid; secondary amino compound | EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug |
fluphenacur | [no description available] | low | 0 | 0 | aromatic ether; benzoylurea insecticide; dichlorobenzene; N-acylurea; organofluorine compound | |
guanoclor | [no description available] | low | 0 | 0 | dichlorobenzene | |
tridiphane | [no description available] | low | 0 | 0 | dichlorobenzene | |
tetraconazole | [no description available] | low | 0 | 0 | dichlorobenzene; ether; organofluorine compound; triazoles | |
n-(2,4-dichloro-5-(4-(difluoromethyl)-4,5-dihydro-3-methyl-5-oxo-1h-1,2,4-triazol-1-yl)phenyl)methanesulfonamide | [no description available] | low | 0 | 0 | dichlorobenzene; organofluorine compound; sulfonamide; triazoles | agrochemical; EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide |
fluquinconazole | [no description available] | low | 0 | 0 | conazole fungicide; dichlorobenzene; organofluorine compound; quinazolines; triazole fungicide; triazoles | antifungal agrochemical; EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor |
tolclofos-methyl | [no description available] | low | 0 | 0 | dichlorobenzene; organic thiophosphate | antifungal agrochemical |
penconazole | [no description available] | low | 0 | 0 | dichlorobenzene; triazoles | |
chlorfluazuron | [no description available] | low | 0 | 0 | benzoylurea insecticide; dichlorobenzene; organochlorine insecticide; organofluorine insecticide | |
fenpiclonil | [no description available] | low | 0 | 0 | dichlorobenzene; nitrile; pyrroles | antifungal agrochemical |
teflubenzuron | [no description available] | low | 0 | 0 | dichlorobenzene; difluorobenzene; N-acylurea | environmental contaminant; insecticide; xenobiotic |
hexafluoron | [no description available] | low | 0 | 0 | aromatic ether; benzoylurea insecticide; dichlorobenzene; N-acylurea; organochlorine insecticide; organofluorine insecticide | |
sr141716 | [no description available] | low | 0 | 0 | amidopiperidine; carbohydrazide; dichlorobenzene; monochlorobenzenes; pyrazoles | anti-obesity agent; appetite depressant; CB1 receptor antagonist |
4,4'-bis(methylsulfonyl)-2,2',5,5'-tetrachlorobiphenyl | [no description available] | low | 0 | 0 | biphenyls; dichlorobenzene; sulfone | |
4'-hydroxydiclofenac | [no description available] | low | 0 | 0 | dichlorobenzene; monocarboxylic acid; phenols; secondary amino compound | allergen; drug metabolite |
zoxamide | [no description available] | low | 0 | 0 | alpha-chloroketone; benzamides; dichlorobenzene | |
1-((3,5-dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone | [no description available] | low | 0 | 0 | dichlorobenzene; differentiation-inducing factor; monomethoxybenzene; resorcinols | eukaryotic metabolite; signalling molecule |
1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl-)-1-pentanone | [no description available] | low | 0 | 0 | dichlorobenzene; differentiation-inducing factor; monomethoxybenzene; resorcinols | eukaryotic metabolite; signalling molecule |
cgp 52432 | [no description available] | low | 0 | 0 | dichlorobenzene | |
spirodiclofen | [no description available] | low | 0 | 0 | dichlorobenzene; gamma-lactone; organochlorine acaricide; oxaspiro compound | |
n-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide | [no description available] | low | 0 | 0 | anilide fungicide; aromatic amide; dichlorobenzene; monocarboxylic acid amide; phenols | antifungal agrochemical; EC 1.14.13.72 (methylsterol monooxygenase) inhibitor; sterol biosynthesis inhibitor |
2-(2,4-dichlorophenoxy)-N-(3-pyridinyl)acetamide | [no description available] | low | 0 | 0 | dichlorobenzene | |
3,5-dichlorotyrosine | [no description available] | low | 0 | 0 | chloroamino acid; dichlorobenzene; dihalogenated L-tyrosine; non-proteinogenic L-alpha-amino acid | |
pd 173955 | [no description available] | low | 0 | 0 | aryl sulfide; dichlorobenzene; methyl sulfide; pyridopyrimidine | tyrosine kinase inhibitor |
mln 4760 | [no description available] | low | 0 | 0 | dichlorobenzene; L-histidine derivative; L-leucine derivative | anti-inflammatory agent; EC 3.4.17.23 (angiotensin-converting enzyme 2) inhibitor |
olanexidine | [no description available] | low | 0 | 0 | dichlorobenzene | |
2-(2,4-dichlorophenoxy)-N-(2-furanylmethyl)acetamide | [no description available] | low | 0 | 0 | dichlorobenzene | |
2-[[5-(2,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]thio]acetic acid butyl ester | [no description available] | low | 0 | 0 | dichlorobenzene | |
2-[[5-(2,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]thio]acetic acid ethyl ester | [no description available] | low | 0 | 0 | dichlorobenzene | |
5,6-dichloro-1-ethyl-1,3-dihydro-2h-benzimidazol-2-one | [no description available] | low | 0 | 0 | dichlorobenzene | |
3-[(2,6-dichlorophenyl)methylthio]-4-methyl-5-thiophen-2-yl-1,2,4-triazole | [no description available] | low | 0 | 0 | dichlorobenzene | |
1-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-yl)ethanol | [no description available] | low | 0 | 0 | dichlorobenzene | |
N-[2-[5-[(2,4-dichlorophenyl)methylsulfonyl]-1,3,4-oxadiazol-2-yl]ethyl]carbamic acid tert-butyl ester | [no description available] | low | 0 | 0 | dichlorobenzene | |
6-(2,4-dichlorophenyl)-1,5-diazabicyclo[3.1.0]hexane | [no description available] | low | 0 | 0 | dichlorobenzene | |
3-[(2,4-dichlorophenyl)methylthio]-1,2,4-thiadiazol-5-amine | [no description available] | low | 0 | 0 | dichlorobenzene | |
2-(2,4-dichlorophenyl)-3,5-dihydro-1H-pyrazolo[3,4-d]triazol-6-amine | [no description available] | low | 0 | 0 | dichlorobenzene | |
5-[(2,4-dichlorophenoxy)methyl]-N-[1-[(2-fluorophenyl)methyl]-3-pyrazolyl]-2-furancarboxamide | [no description available] | low | 0 | 0 | dichlorobenzene | |
1-[[2-(2,4-dichlorophenoxy)-1-oxoethyl]amino]-3-(4-fluorophenyl)thiourea | [no description available] | low | 0 | 0 | dichlorobenzene | |
[4-[[5-(2,4-dichlorophenyl)-3-isoxazolyl]-oxomethyl]-1-piperazinyl]-(2-furanyl)methanone | [no description available] | low | 0 | 0 | dichlorobenzene | |
5-(2,4-dichlorophenyl)-N-(4-methyl-2-thiazolyl)-2-furancarboxamide | [no description available] | low | 0 | 0 | dichlorobenzene | |
5-(2,5-dichlorophenyl)-N-(2-propyl-5-tetrazolyl)-2-furancarboxamide | [no description available] | low | 0 | 0 | dichlorobenzene | |
4-[2-[(3,4-dichlorophenyl)methylthio]-6-[(methylthio)methyl]-4-pyrimidinyl]morpholine | [no description available] | low | 0 | 0 | dichlorobenzene | |
3-[5-[(3,4-dichlorophenyl)methylthio]-4-ethyl-1,2,4-triazol-3-yl]-1-phenyl-4-pyridazinone | [no description available] | low | 0 | 0 | dichlorobenzene | |
5-[3-[(2,4-dichlorophenyl)methoxy]-2-thiophenyl]-1,2-dihydro-1,2,4-triazole-3-thione | [no description available] | low | 0 | 0 | dichlorobenzene | |
2-(2,4-dichlorophenyl)-5-[2-(methylthio)phenyl]-1,3,4-oxadiazole | [no description available] | low | 0 | 0 | dichlorobenzene | |
4-[2-[(2,4-dichlorophenyl)methylthio]-6-methyl-4-pyrimidinyl]morpholine | [no description available] | low | 0 | 0 | dichlorobenzene | |
4-(2,4-dichlorophenoxy)-N-(3-pyridinyl)butanamide | [no description available] | low | 0 | 0 | dichlorobenzene | |
4-(2,4-dichlorophenoxy)butanoic acid [2-oxo-2-[(phenylmethyl)amino]ethyl] ester | [no description available] | low | 0 | 0 | dichlorobenzene | |
2-((3-(2,3-dichlorophenoxy)propyl)amino)ethanol | [no description available] | low | 0 | 0 | dichlorobenzene | |
2-(2,4-dichloro-6-methylphenoxy)-N-(2-furanylmethyl)acetamide | [no description available] | low | 0 | 0 | dichlorobenzene | |
4-[3-(2,4-dichlorophenyl)-5-isoxazolyl]-2-pyrimidinamine | [no description available] | low | 0 | 0 | dichlorobenzene | |
yoda 1 | [no description available] | low | 0 | 0 | aromatic compound; dichlorobenzene; organic sulfide; pyrazines; thiadiazoles | glycine transporter 2 inhibitor; piezo1 agonist |
3-[[(2,4-dichlorophenyl)methylthio]methyl]-4-propan-2-yl-1H-1,2,4-triazole-5-thione | [no description available] | low | 0 | 0 | dichlorobenzene | |
N-[amino(1-pyrrolidinyl)methylidene]-3-(2,6-dichlorophenyl)-5-methyl-4-isoxazolecarboxamide | [no description available] | low | 0 | 0 | dichlorobenzene | |
N-[2-(2,4-dichlorophenyl)ethyl]-2-[[5-[1-(dimethylamino)propyl]-1,3,4-oxadiazol-2-yl]thio]acetamide | [no description available] | low | 0 | 0 | dichlorobenzene | |
nnd 502 | [no description available] | low | 0 | 0 | dichlorobenzene | |
fenchlorazole-ethyl | [no description available] | low | 0 | 0 | dichlorobenzene | |
omoconazole | [no description available] | low | 0 | 0 | dichlorobenzene | |
u-50488 | [no description available] | low | 0 | 0 | dichlorobenzene; monocarboxylic acid amide; N-alkylpyrrolidine | analgesic; antitussive; calcium channel blocker; diuretic; kappa-opioid receptor agonist |
vx-745 | [no description available] | low | 0 | 0 | aryl sulfide; dichlorobenzene; difluorobenzene; pyrimidopyridazine | anti-inflammatory drug; apoptosis inducer; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor |
5-hydroxydiclofenac | [no description available] | low | 0 | 0 | dichlorobenzene; monocarboxylic acid; phenols; secondary amino compound | allergen; drug metabolite |
fipronil sulfone | [no description available] | low | 0 | 0 | (trifluoromethyl)benzenes; dichlorobenzene; nitrile; pyrazoles; sulfone | marine xenobiotic metabolite |
3-(2-chlorophenyl)-N-[5-(2,4-dichlorophenyl)-1,3,4-thiadiazol-2-yl]-5-methyl-4-isoxazolecarboxamide | [no description available] | low | 0 | 0 | dichlorobenzene | |
3-[2-(2,4-dichlorophenoxy)ethoxy]-6-methyl-2-nitropyridine | [no description available] | low | 0 | 0 | dichlorobenzene | |
5-[(2,4-dichlorophenoxy)methyl]-N-[3,5-dimethyl-1-[(2,3,4,5,6-pentafluorophenyl)methyl]-4-pyrazolyl]-2-furancarboxamide | [no description available] | low | 0 | 0 | dichlorobenzene | |
(3,5-dichloroanilino)thiourea | [no description available] | low | 0 | 0 | dichlorobenzene | |
N(2)-carbamimidoyl-N-{2-[4-(3-{4-[(5-carboxyfuran-2-yl)methoxy]-2,3-dichlorophenyl}-1-methyl-1H-pyrazol-5-yl)piperidin-1-yl]-2-oxoethyl}-D-leucinamide | [no description available] | low | 0 | 0 | D-leucine derivative; dichlorobenzene; furoic acid; glycine derivative; guanidines; pyrazolylpiperidine | |
bosutinib | [no description available] | low | 0 | 0 | aminoquinoline; aromatic ether; dichlorobenzene; N-methylpiperazine; nitrile; tertiary amino compound | antineoplastic agent; tyrosine kinase inhibitor |
oxiconazole | [no description available] | low | 0 | 0 | conazole antifungal drug; dichlorobenzene; imidazole antifungal drug; imidazoles; oxime O-ether | antiinfective agent |
guanabenz acetate | [no description available] | low | 0 | 0 | dichlorobenzene | geroprotector |
guanabenz | [no description available] | low | 0 | 0 | dichlorobenzene | |
N-(3,4-dichlorophenyl)-6-(1-imidazolyl)-3-pyridazinamine | [no description available] | low | 0 | 0 | dichlorobenzene | |
diniconazole | [no description available] | low | 0 | 0 | dichlorobenzene; olefinic compound; secondary alcohol; triazoles | |
chlorproguanil | [no description available] | low | 0 | 0 | dichlorobenzene | |
noviflumuron | [no description available] | low | 0 | 0 | aromatic ether; benzoylurea insecticide; dichlorobenzene; organofluorine compound | |
chir 99021 | [no description available] | low | 0 | 0 | aminopyridine; aminopyrimidine; cyanopyridine; diamine; dichlorobenzene; imidazoles; secondary amino compound | EC 2.7.11.26 (tau-protein kinase) inhibitor |
vilanterol | [no description available] | low | 0 | 0 | benzyl alcohols; dichlorobenzene; ether; phenols; secondary amino compound | beta-adrenergic agonist; bronchodilator agent |
gw 842166x | [no description available] | low | 0 | 0 | dichlorobenzene | |
pha 665752 | [no description available] | low | 0 | 0 | dichlorobenzene; enamide; indolones; N-acylpyrrolidine; pyrrolecarboxamide; secondary carboxamide; sulfone; tertiary carboxamide | antineoplastic agent; c-Met tyrosine kinase inhibitor |
fluopicolide | [no description available] | low | 0 | 0 | benzamide fungicide; benzamides; dichlorobenzene; monochloropyridine; organofluorine compound | antifungal agrochemical |
gamendazole | [no description available] | low | 0 | 0 | alpha,beta-unsaturated monocarboxylic acid; dichlorobenzene; indazoles; olefinic compound; organofluorine compound | antispermatogenic agent; eukaryotic translation elongation factor 1alpha 1 inhibitor; Hsp90 inhibitor; synthetic oral contraceptive |
at 7519 | [no description available] | low | 0 | 0 | dichlorobenzene; piperidines; pyrazoles; secondary carboxamide | antineoplastic agent; EC 2.7.11.22 (cyclin-dependent kinase) inhibitor |
s 1812 | [no description available] | low | 0 | 0 | dichlorobenzene; organochlorine insecticide; organofluorine insecticide | |
3-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)pyrazol-4-yl]pyridin-2-amine | [no description available] | low | 0 | 0 | aminopyridine; aromatic ether; dichlorobenzene; organofluorine compound; pyrazolylpiperidine; racemate | antineoplastic agent; biomarker; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor |
2-[(2,4-dichlorophenyl)methylthio]-1-methylimidazole | [no description available] | low | 0 | 0 | dichlorobenzene | |
avilamycin a | [no description available] | low | 0 | 0 | benzoate ester; cyclic acetal; dichlorobenzene; oligosaccharide derivative; ortho ester; oxaspiro compound; phenols; tertiary alpha-hydroxy ketone | antimicrobial agent; bacterial metabolite |
gsk 1016790a | [no description available] | low | 0 | 0 | 1-benzothiophenes; aromatic primary alcohol; dichlorobenzene; N-acylpiperazine; sulfonamide; tertiary carboxamide | TRPV4 agonist |
poziotinib | [no description available] | low | 0 | 0 | acrylamides; aromatic ether; dichlorobenzene; diether; monofluorobenzenes; N-acylpiperidine; quinazolines; secondary amino compound; substituted aniline | antineoplastic agent; apoptosis inducer; epidermal growth factor receptor antagonist |
ixazomib | [no description available] | low | 0 | 0 | benzamides; boronic acids; dichlorobenzene; glycine derivative | antineoplastic agent; apoptosis inducer; drug metabolite; orphan drug; proteasome inhibitor |
N-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-(1-tetrazolyl)acetamide | [no description available] | low | 0 | 0 | dichlorobenzene | |
aripiprazole lauroxil | [no description available] | low | 0 | 0 | aromatic ether; delta-lactam; dichlorobenzene; dodecanoate ester; N-alkylpiperazine; N-arylpiperazine; quinolone | H1-receptor antagonist; prodrug; second generation antipsychotic; serotonergic agonist |
3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(6-(4-(4-ethylpiperazin-1-yl)-phenylamino)pyrimidin-4-yl)-1-methylurea | [no description available] | low | 0 | 0 | aminopyrimidine; dichlorobenzene; N-alkylpiperazine; N-arylpiperazine; phenylureas | antineoplastic agent; fibroblast growth factor receptor antagonist |
chir 98014 | [no description available] | low | 0 | 0 | aminopyrimidine; C-nitro compound; diaminopyridine; dichlorobenzene; imidazoles; secondary amino compound | antineoplastic agent; apoptosis inducer; EC 2.7.11.26 (tau-protein kinase) inhibitor; hypoglycemic agent; tau aggregation inhibitor; Wnt signalling activator |
LimKi 3 | [no description available] | low | 0 | 0 | 1,3-thiazoles; dichlorobenzene; organofluorine compound; pyrazoles; secondary carboxamide | LIM kinase inhibitor |
2-(4-chloroanilino)-5-[(2,3-dichlorophenyl)methyl]-4-thiazolone | [no description available] | low | 0 | 0 | dichlorobenzene | |
2,3-dihydroxybiphenyl | [no description available] | low | 0 | 0 | catechols; hydroxybiphenyls | |
2-phenylphenol | [no description available] | low | 0 | 0 | hydroxybiphenyls | antifungal agrochemical; environmental food contaminant |
4,4'-dihydroxybiphenyl | [no description available] | low | 0 | 0 | hydroxybiphenyls | |
2,2'-biphenol | [no description available] | low | 0 | 0 | hydroxybiphenyls | |
altenusin | [no description available] | low | 0 | 0 | aromatic ether; carboxybiphenyl; catechols; hydroxybiphenyls; polyphenol | antifungal agent; fungal metabolite |
Article | Year |
---|---|
Hydroxylated polychlorinated biphenyls selectively bind transthyretin in blood and inhibit amyloidogenesis: rationalizing rodent PCB toxicity. Chemistry & biology, Volume: 11, Issue: 12 | 2004 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |